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ABSTRACT 
Deepak Kumar Jha: Role of histone methylation and variants in genome function 
(Under the direction of Brian Strahl) 
 
The eukaryotic genome is compacted in the form of chromatin, which is a complex of 
DNA and histone proteins. Regulation of chromatin structure influences all aspects of cellular 
processes, especially the DNA –dependent processes. The basic unit of chromatin is composed 
of DNA wrapped around a core of octameric histones, forming what is called the nucleosome 
core particle. The dynamic nature of this structure implies that there will be well-regulated 
processes and pathways that help in the interchanges between one form of chromatin and 
another.  In chapter 1, I outline the current state of literature for mechanisms that regulate 
chromatin structure, with special emphasis on histone modifications and histone variants. I also 
review the literature for genome maintenance and how chromatin regulates genomic integrity.   
One of the most critical histone modifications that regulate chromatin structure is the 
methylation of histone H3 at lysine 36 (H3K36me). Set2 catalyzes H3K36me and its function is 
well established in regulation of chromatin structure during transcription elongation, but its 
function in maintaining the integrity of yeast genome was not known. In chapter 2, I describe its 
novel function in regulating chromatin structure after double strand break (DSB). Work from 
chapter 2 reveals that Set2-dependent H3K36me (2/3) and its interaction with RNA polymerase
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II (RNAPII) is critical for surviving DSBs after phleomycin. It also shows that H3K36me is 
critical for full activation of a DSB checkpoint. Furthermore, I show that H3K36me is also 
important for chromatin remodeling around a DSB, abrogation of which subsequently facilitates 
inappropriate end-processing. In chapter 3, I describe our ongoing efforts to delineate the 
dynamic incorporation/eviction of the histone variant Htz1 in yeast. I show that deletion of NAP1 
and CHZ1 results in increased retention of Htz1 in yeast chromatin, and show that there are two 
non-overlapping surfaces on the Htz1-H2B nucleosome. Furthermore we show that specific point 
mutations of these residues have biochemical and biological effects on cells. In chapter 4, I 
describe the implications of my research, place it in the wider context of chromatin research and 
discuss the contribution of H3K36me and Htz1 in tumorigenesis. 
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PREFACE 
 
Chapter 2 is an extended version of work published in Nature Communications, June 9th 
2014 titled ‘An RNA Polymerase II-coupled function for histone H3K36 methylation in 
checkpoint activation and DSB repair’ (Jha &Strahl, 2014; Nature Communications; June 9th 
1). 
  
Chapter 3 is derived from a manuscript being prepared for Nature Structural and 
Molecular Biology. This will be co-first authored with Srinivas Ramachandran and Michael 
Parra.  
Parts of figures and text in Chapter 4 were modified with permission from an article 
published in Nature Structural and Molecular Biology (2014) titled “SET-ting the stage for 
DNA repair” (Jha, Strahl et.al 2014) 2.  
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CHAPTER 1: REGULATION OF CHROMATIN STRUCTURE AND ITS INFLUENCE 
ON GENOME FUNCTIONS 
 
1.1 Introduction to chromatin structure 
Prokaryotes and eukaryotes are the two major branches of life on earth. The 
fundamental difference between the two classes is the presence of a nucleus, a central organelle 
tasked with storing the genetic material in the form of DNA. In the case of eukaryotes, the DNA 
is packaged with histone proteins inside the nucleus 3. In the case of humans, the total genome 
size is about 3 billion base-pairs, which has to fit into a nucleus of about 10 micron in diameter – 
a packaging ratio of about 106 4. To accomplish that cells compact the genome by wrapping the 
DNA around the core of 8 histone proteins. Histone proteins are highly basic proteins and 
typically they consists of two copies each of histone H2A, H2B, H3 and H4. One-hundred and 
forty-seven base pair of DNA double helix wraps around the core octamer of histone proteins, 
forming what is called the nucleosome core particle (NCP) 4. The NCPs are the fundamental 
building blocks of chromatin and serve multiple purposes in regulating the genome activity and 
integrity 4. NCPs package the genome to accommodate it in the nuclei, restrict access to the 
DNA to prevent DNA damage, hide or expose regulatory sequences for appropriate modulation 
of genome function.  In addition to the well-established role of nucleosomes in chromatin 
compaction, eukaryotic genomes also undergo several long-range interactions that further pack 
the genome and organize the nuclei in specific domains based on access to DNA, transcription 
activity, and association with the nuclear membrane 5,6. Such three-dimensional organizations 
have come to occupy a central focus in our understanding of nuclear architecture and function 5,6.  
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1.2 Mechanisms of regulating chromatin structure:  
During the life cycle of a cell, it has to grow by acquiring nutrients, divide and reproduce and 
maintain a relatively error free genome while braving a variety of stresses- both endogenous and 
exogenous. In terms of the cell’s life, it needs to obtain nutrients and grow (G1- phase of the cell 
cycle), divide and reproduce (S-G2, M) and maintain the fidelity of its genome 7,8. All these 
processes necessitate a dynamic chromatin transactions- alteration of chromatin structure 
between various levels of access, both at the local (G1, S and during DNA repair) and global 
(G2-M and DNA repair) levels. To accomplish this, cells have a variety of mechanisms that 
include: modification of histone proteins, using the energy of ATP to remodel the chromatin 
structure, using variant histones with altered biochemical and biophysical properties, and using 
RNA-based mechanisms 9-12. All these mechanisms will be described in the following sub-
sections: 
a) Histone Modifications: Histone proteins are highly basic proteins that bind, rather 
tightly, to DNA through electrostatic interactions 3,4. Addition of covalent chemical moieties to 
histone proteins can alter the biochemical/ biophysical properties of histone proteins and disrupt 
either general DNA-histone contact or locally alter the histone-DNA interaction 13. For example, 
addition of a negatively charged acetyl group on lysine residues of histone proteins can disrupt 
the strong electrostatic interactions between DNA and histone proteins 14-16. The early stage of 
chromatin research was primarily reliant on this simplistic interpretation of histone 
modifications. Additionally, it was also assumed that the modifications would generally occur on 
the unstructured tails of the histone protein and leave the central structured part of histone 
untouched. Discovery of histone methylation, and in particular modification of core residues in 
histones (H3 Lysine 79 methylation; H3K79me) (van Leeuwen, 2002 #24) and acetylation of 
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lysine 56 of histone H3; H3K56Ac 17) challenged the afore-mentioned simplistic idea. To date, a 
large number of histone modifications have been discovered that span a vast chemical space such 
as acetylation, methylation, phosphorylation, ubiquitination, palmitoylation, crotonylation and 
sumoylation 11,18-21. The underlying mechanism that seems to provide a reasonable explanation 
for these modifications comes from the ‘histone code’ hypothesis 22-25. The ‘Histone code’ 
hypothesis, as proposed about a decade ago, expounded on the possibility that individual histone 
modifications or their combinations will act as a sign-post for the genome and recruit protein(s) 
that can subsequently possess enzymatic activity capable of dynamically altering chromatin 
structure and effecting biological functions 22-25. Retrospectively, although quite simplistic, the 
histone code hypothesis serves as a useful way to understand how these myriad histone 
modifications can result in multiple biological outcomes. Given the complexity of these histone 
modifications, lack of strict ‘keys’ that can deduce their downstream function, histone 
modifications should be (and are to some extent) thought of more as a ‘language’ than ‘code’ – 
since downstream function of several of these histone modifications are dependent on context 
similar to words having different meaning in different contexts 26-28. The array of histone 
modifications that have been discovered in model organisms as well as human cells is quite large 
and complex and with the technological advancements in discovery of cellular post-translational 
modifications (PTMs), the field has exploded in recent times 29. The study of histone PTMs has 
impacted our understanding of gene regulation, DNA repair, cell division, and organismal 
development 29.  
b) ATP-dependent chromatin remodelers: An attractive way of accessing the underlying the 
DNA sequence of the chromatin is to disrupt the nucleosome, either partially or completely 9,30-
34. Cells have enzymes that use the energy stored in ATP, and accomplish exactly that. These 
  
 4 
enzymes belong to the class of ATP-dependent chromatin remodelers. Some of the defining 
features of proteins belonging to this class are: i) Ability to bind to DNA and nucleosomal 
components, including histone modifications ii) DNA-dependent ATPase activity, albeit the 
DNA structures that activate the ATPase can vary depending upon the class of remodeler and iii) 
presence of multiple domains in the proteins, some of which can be used for protein-protein 
interactions and modulation of ATPase activity 9.  
Essentially, all ATP-dependent remodelers perform one of the following functions: a) 
reposition nucleosomes to either unravel the underlying DNA sequence or hide it and b) disrupt 
the nucleosome structure either by eviction of histone dimers or altering the octamer composition 
by incorporating histone variants 9,35,36. Many of these ATP-dependent remodelers exist as multi-
protein complexes and are required for multiple cellular functions involving dynamic changes in 
chromatin structures 9,36. For example, the INO80 ATP-dependent remodeler functions during 
double strand break (DSB) repair, transcription regulation, DNA replication 37 and the SWR1 
complex is similarly required for maintenance of chromatin organization during gene expression 
and DNA repair 38. In higher organisms, various ATP-dependent remodelers are crucial for 
appropriate developmental progression. For example, the Brg1 null mouse is embryonically 
inviable 39. An interesting mechanism to regulate the function of these remodelers is to alter their 
subunit composition- resulting in widely different cellular outcomes. For example, work from the 
Crabtree lab has shown that a critical exchange of subunits in hSWI/SNF occurs during 
vertebrate development 40. For example, appropriate neural differentiation is dependent upon 
incorporation of different versions of BAF45 and BAF53 subunits (BAF45 and 53a in the 
neuronal progenitors vs. BAF45/53b in post-mitotic neurons) 40. In sum, ATP-dependent 
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chromatin remodelers function, both in isolation and in combination with histone modifications 
to dynamically alter the chromatin structure and influence cellular processes. 
c)    Histone variants: A typical nucleosome consists of two copies each of histones H2A, 
H2B, H3 and H4. Additionally, in higher eukaryotes, there exists histone H1, which acts as 
linker histone between NCPs 4. However, there are a large number of atypical histones, called 
histone variants that differ in sequence, genomic location and functions 41,42. Some of the more 
ubiquitous variants for the histones are listed below:  
Table 1: Major histone variants across eukaryotes and their functions 41 
Variant Species Function 
MacroH2A All vertebrates X-chromosome inactivation 
H2ABbd All vertebrates Transcription 
H2A.X All eukaryotes Genome integrity, Transcription 
H2A.Z All eukaryotes Transcription, genome integrity 
CenH3 All eukaryotes Centromere  
H3.3 All eukaryotes Transcription 
  
Besides these more common histone variants, there are species-specific variants such as 
histone H10 in mouse 43. Typically, these histones are regulated in a manner quite different from 
the canonical histones. Canonical histones are synthesized in an S-phase dependent manner 
while the variants may not be subjected to the same set of regulatory mechanisms 44,45. Histone 
variants are also differentially incorporated into the chromatin- temporally or spatially. For 
example, H2A.Z containing nucleosomes are present around the transcription start sites (TSS) 
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and in the sub-telomeric heterochromatin 46-48. They are specifically excluded from within the 
gene bodies 46-48. Another example is incorporation of H2A.X around a DNA damage sites in 
eukaryotes 49. Presence of H2A.X (and its subsequent phosphorylation) acts as one of the first 
signals of DNA damage response in cells. Another recently described function of H2A.X is its 
ability to function as a ‘bookmark’ during stem cell differentiation 50. Presence of histone 
variants alters the biophysical characters of the nucleosomes as well. For example the H2A.Z 
containing nucleosome is substantially more prone to salt-dependent dissociation than an H2A-
containing nucleosome 51. Another layer of complexity arises when the histone variants are also 
modified (H2A.X phosphorylation at Serine 139 is described above; sumoylation of H2A.Z is 
critical for relocation of a double strand break to the nuclear periphery) [Kalocsay, 2009 #62]. 
Recently, a large number of histone variants and their mutations have been associated with 
different kinds of cancers. Most notably, mutation at lysine 36 or lysine 9 of the histone variant 
H3.3 to methionine (H3.3K36M or H3.3K9M) have been shown as drivers of pediatric 
glioblastomas 42,52-54, again reinforcing the idea that histone variants perform critical functions in 
regulating chromatin structure and genome function.  
d)    Non-coding RNA: Biochemical purification of chromatin results in recovery of about 
twice as much RNA as DNA, which led to the conception that RNA can regulate chromatin 
structure and function 55. Over the past few years, a large number of RNAs have been isolated 
that directly impact chromatin structure, and chromatin-templated processes in cells 55. These 
RNAs comprise the now famous long non-coding RNAs (lncRNAs). One of the most famous 
lncRNAs is the Xist RNA that regulates X-chromosome inactivation 55,56. Xist is synthesized 
from one of the two X-chromosomes and then results in recruitment of the chromatin modifier, 
Polycomb repressor complex (PRC2), to the silenced X-chromosome 55,56. PRC2 catalyzes 
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H3K27me3, which is associated with transcriptional silencing and thereby promotes X-
chromosome inactivation in higher humans 55,56. PRC2 also associates with another lncRNA, 
HOTAIR, which recruits it to several sites in the genome to control gene-silencing 57. A new 
class of RNAs has been recently discovered, called enhancer RNAs (eRNAs), which are 
lncRNAs that emanate from enhancer regions marked with H3K4me1, H3K27Ac and p300 
histone acetyltransferase protein 58. Such eRNAs were shown to be critical for gene activation of 
nearby genes 58. In sum, non-coding RNAs in general and lncRNAs in particular have become 
increasingly important in regulation of chromatin structure and function.  
1.3 Lysine Methylation of Histones  
A major class of histone modifications in eukaryotes is the methylation of lysines and 
arginines in histones, predominantly histone H3 and histone H4. Methylation of histone H3 and 
H4 have been extensively studied and these modifications have been shown to be critical for 
regulation of transcription, replication, DNA replication, mitosis, meiosis and appropriate 
developmental progression. For histone H3, the most well studied methylation involves 
methylation of histone H3 lysine 4, 9, 27, 36 and 79 while for histone H4 the most well studied 
methylation is at lysine 20.  
Two classes of methyltransferases catalyze lysine methylation of histones: SET domain 
and non-SET domain methyltransferase. SET domain stands for SuVar3–9, Enhancer of Zeste, 
Trithorax and forms the largest class of histone methyltransferase (HMTs) 59. There are seven 
main families, across all eukaryotes, for the SET domain containing lysine methyltransferases- 
SET1, SET2, SUV39, EZ, RIZ, SMYD and SUV4-20 59. In addition, PR-Set7/Set8 and Set7/9 
are two additional HMTs, which do not belong to a particular class. Some SET domain 
containing HMTs can act on peptides (e.g. G9a), while others prefer nucleosomal substrates 
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(e.g. Set2) 59. HMTs have specificity in terms of the methylation states (mono-, di- and tri-) that 
they can achieve on the lysine residues. Different methylation states tend to have different 
localization in the genome and hence different functions as well. In budding yeast, the major 
SET domain containing HMTs are Set1, Set2 and Set5, while the non-SET domain containing 
HMT is Dot1.   
Set1 is required for methylation of lysine 4 on histone H3 (H3K4me1/2/3) 60. H3K4me 
is associated with active transcription, where H3K4me3 is present in the promoter and 5’ end of 
genes while H3K4me2 is spread across the gene body 61. In contrast, H3K4me1 is enriched 
towards the 3’ end of genes 61. In vitro experiments support the idea that presence of H3K4me3 
activates transcription 62. In human cells, H3K4me1 is associated with enhancers regions of the 
gene 63. Beyond regulation of transcription elongation, H3K4me2 has also been associated with 
positive regulation of replication initiation in budding yeast 64. Consistent with the yeast data, 
H3K4me is also critical for replication in human cells 65. Set1 and H3K4me has also been 
recently linked with maintenance of genome integrity, specifically with the regulation of DSB 
sensing and repair 66. Interestingly, H3K4me is also associated with initiation and regulation of 
meiotic double strand break and overall efficiency of meiosis- both in yeast and humans 67,68.  
Set5 is a newly discovered HMT, responsible for mono methylation of H4 K5, 8 and 12 
69. It was proposed that Set5 is required for maintenance of appropriate chromatin structure 
along with global regulators of chromatin structure like NuA4 and COMPASS (Set1-containing 
complex) 69. This regulation of chromatin structure by Set5 was linked to stress response in 
budding yeast, but no clear mechanism was elucidated 69. Dot1 is the sole non-SET domain 
HMT in budding yeast. Dot1 is responsible for methylation of H3K79 (all three forms of 
methylation) 70. Dot1 stands for Disuptor of Telomeric silencing, derived from its function in 
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regulating telomeric silencing of genes 70. H3K79me is also present in the gene bodies but its 
specific function and proteins that can recognize it are not clearly understood 63. H3K79me has 
significant role in maintenance of genomic integrity- stabilizing Rad9 on the chromatin around 
DSBs, activating DNA damage response in response to MMS and replication stress, and 
negatively regulating resection 71. In human cells, Dot1L (human homolog of Dot1) is required 
for H3K79me1/2 and is necessary for embryonic development 72,73. Tissue specific loss of 
Dot1L revealed that Dot1 is critical for cardiac development 73.  
 Set2 and methylation of H3K36 will be dealt with in detail in the following 
section.  
1.4 Description of Set2/H3K36me from yeast to man: 
As mentioned before, methylation of lysine 36 (H3K36me) is a highly conserved 
histone methylation from yeast to humans 74. This modification occurs at position 36 of 
histone H3, a rather interesting position from the structural perspective. Lysine 36 is 
close to the entry– and exit– points of DNA in a nucleosome core particle. Therefore, any 
modification of this position will likely influence the structure of nucleosome as well, 
besides the modifications acting as recruitment platform for various protein complexes. 
H3K36me was discovered in budding yeast and Set2 was the enzyme that was implicated 
for this histone modification 75. Set2 (and its homologs and orthologs) are present from 
yeast to human 74.  
Set2 is a nucleosomal histone methyltransferase belonging to the SET-domain 
class of methyltransferases 74. The human homolog of yeast Set2 is SETD2, which is 
frequently mutated in clear cell renal cell carcinoma, and some classes of breast cancer 
and glioblastoma 74,76. In yeast, Set2 is capable of all forms of H3K36 methylation 
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(H3K36me1/2 and 3) while in higher organisms (primarily metazoans) the capability is 
restrictive 74. Human SETD2 can only catalyze H3K36me3 while there are multiple 
H3K36me1/2 methyltransferase (NSD (1-3), Ash1L, Setd3, SMYD2 and SETMAR) 74. 
Yeast Set2 is a 733 amino acid long protein and has multiple domains that help in 
catalysis, recruitment to chromatin and protein-protein interactions. The definitive 
catalytic domain (SET) along with accessory domains exists in the extreme N-terminus 
(from residue 1-261) and is capable of catalyzing H3K36me1 and H3K36me2 77. In 
addition, Set2 contains a unique domain in its extreme C-terminus called the Set2-RNA 
Polymerase II (RNAPII) interaction domain (SRI domain) 78,79. It spans from residue 
619-718 and is responsible for recruiting Set2 to the elongating form of RNAPII (hyper-
phosphorylated at serine2 and serine 5 in the CTD of RNAPII) 78,79. Furthermore, there is 
a coiled-coil and a WW domain in the yeast Set2, the functions of which is not clearly 
understood 78. 
In terms of its function, yeast Set2 is very reliant on the presence of hyper-
phosphorylated RNAPII for realizing its full catalytic potential (H3K36me3). During 
transcription cycle, the RNAPII is bound to a gene promoter and is phosphorylated on 
Serine5 of the C-terminal domain of the largest subunit (Rpb1) 80. Subsequently, Bur1 
(and Ctk1) phosphorylate Serine2 in the heptapeptide repeat, YSPTSPS, resulting in 
promoter clearance and productive elongation of RNAPII-dependent transcription 80. This 
elongating RNAPII recruits Set2 to transcribed regions, which results in H3K36me1/2/3 
in gene bodies 78. The distribution of H3K36me1, me2 and me3 is stereotypical: 
H3K36me1 near the 5’ end of genes, H3K36me2 distributed across gene bodies and 
H3K36me3 increases towards the 3’ end of genes 74. To date, the majority of functions of 
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Set2 have been shown to be driven by H3K36me2/3 and no clear function has emerged 
for H3K36me1. For the most part, H3K36me2/3 function in regulating chromatin 
structure in transcribed regions, the mechanisms are described underneath (Figure 1).  
 
Figure 1: A schematic model the function of yeast Set2/H3K36me. During 
transcriptional elongation, a hyper-phosphorylated RNAPII recruits Set2 (in a Ctk1-
dependent manner), which catalyzes H3K36me1, 2 and 3. Presence of H3K36me 
results in the activation of the Rpd3S deacetylase complex (represented here by Eaf3, 
Rco1 and Rpd3), leading to deacetylation of the hyper-acetylated chromatin. 
Additionally, H3K36me-containing nucleosomes also recruit ISWI1b complex 
(shown here as Ioc2, Isw1 and Ioc4), which prevents histone exchange (through an as 
yet unclear mechanism). Furthermore, it is thought that H3K36me-nucleosomes 
physically occlude the function of H3-H4 chaperone, Asf1 (and presumably some 
others as well). In sum, the effect of all these disparate activities is to repress the 
chromatin behind a transcribing RNAPII and prevent intragenic transcription from 
within gene bodies. Model courtesy Brian Strahl.  
 
 
 
For a vast majority of histone modifications, the downstream function is typically 
dependent on protein(s) or complex(es) that recognize the modification and get recruited 
to chromatin. These proteins themselves contain enzymatic functions or protein-protein 
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interaction motifs that result in modulation of chromatin structure- an idea that was the 
cornerstone of the ‘histone code’ hypothesis 22,23,25. In the case of H3K36me, multiple 
groups discovered that H3K36me2/3 is recognized by the Rpd3(S) complex, using the 
methyl-recognizing (chromo and PHD) domains of Eaf3 and Rco1 subunits. Rpd3(S) 
complex contains the Rpd3 histone deacetylase, which removes histone acetylation from 
the open reading frames of genes thereby repressing the chromatin structure 81-83. 
Subsequently, it was clarified that the recruitment of Rpd3S was not dependent on 
H3K36me but its activity was 84. It was also shown that Rpd3S can bind to the CTD of 
RNAPII, and hence a modified model included an RNAPII-dependent recruitment of 
Rpd3S and its activation by H3K36me 84. Additionally, binding of Eaf3 and Rco1 to 
H3K36me2/3 acts to increase their affinity to the transcribing region of the genome 84. 
Furthermore, it was shown that presence of H3K36me per se is inhibitory to the function 
of transcription associated histone chaperones, primarily Asf1 85. H3K36me3 and to some 
extent H3K36me2 physically inhibited the binding of Asf1 (and to some extent FACT 
(Spt16) and Spt6) to nucleosomes and therefore transcription associated histone exchange 
was diminished 85. Further reduction in histone exchange occurred due to combined 
action of the ISWI1b ATP-dependent remodeling complex (that can bind to H3K36me-
nucleosomes) and Chd1 protein 86. In sum, due to the activation of the Rpd3S deacetylase 
complex, and inhibition of histone exchange (by the combined action of Chd1 and the 
ISWI1b ATP-dependent remodeler and physical occlusion by H3K36me3), H3K36me 
maintains a repressed chromatin structure in the wake of a transcribing RNAPII 85,86. 
Consequently, loss of either Set2 (set2Δ) from cells or mutation of H3K36 results in a 
relatively permissive chromatin structure, as evidenced by generation of intragenic 
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transcripts, and resistance to transcriptional stress induced by 6-Azauracil (which reduces 
the GTP pool in cells, resulting in slower transcription) (Figure 1) 85,86. In addition to the 
well-established function of H3K36me during transcription elongation, it was suggested 
that H3K36me1 in budding yeast might positively impact replication initiation, albeit the 
mechanism for this observation is completely unclear 87. Besides the described functions 
of Set2/H3K36me in budding yeast, it was not understood or known, before the 
publication of a part of this dissertation, if Set2 or any of its downstream methylation 
state contributed to genome stability in budding yeast.  
In other eukaryotes, there have been reports of Set2/H3K36me (or Set2 orthologs) 
functioning in diverse arrays of functions. For examples, in humans, the SETD2 protein, 
which catalyzes H3K36me3, was shown to be crucial for regulation of alternative 
splicing of FGF receptor 88 and subsequently shown that even global regulation of 
alternative splicing was dependent on H3K36me3 (and SETD2) 89. In addition, SETD2 
was shown to regulate the recruitment of MSH6, a repair protein that functions in 
mismatch repair, to chromatin during S-phase 90. Consistent with this notion, clear cell 
renal carcinoma patients showed increased mutation rate when SETD2 was non-
functional 90,91. In Drosophila melanogaster, H3K36me2 catalyzed by Mes-4 and 
H3K36me3 catalyzed by dSetd2 have opposing effects on histone acetylation, 
specifically H4K16Ac 92. The opposing activity of H3K36me2 vs. H3K36me3 results in 
fine-tuned H4K16Ac levels during transcription elongation 92. Recently, Mes4 has been 
shown to co-purify with dCTCF and another insulator binding protein in Drosophila 
melanogaster, Beaf2 93. The co-purification of Mes4 and its requirement for subsequent 
transcription-associated H3K36me3 (which is dependent upon dSetd2) led authors to 
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conclude that H3K362/3 helps in maintaining H3K27me3 repressive domains in flies 93. 
In conclusion, H3K36me is a highly conserved histone modification, from yeast to 
humans, which regulate chromatin structure during transcription as well as other DNA-
templated processes.  
1.5 Regulation of chromatin structure by Htz1/H2A.Z:  
A typical nucleosome consists of 2 copies each of core histones –H2A, H2B, H3 and H4. 
However, depending upon the genomic location, transcription status, cell cycle and stress 
signaling, atypical histones can get incorporated into the chromatin. These atypical histones, 
called histone variants, change the physico-chemical properties of nucleosomes and thus 
dynamically regulate chromatin structure and function 41. One of the most critical histone 
variants is Htz1 (in yeast) and H2A.Z in humans 41. Htz1/H2A.Z is a variant of histone H2A, 
with about 60% sequence identity with H2A but the amino acid sequence in the C-terminus of 
Htz1/H2A.Z is more acidic than the H2A 94. The resulting change in the amino acids in the C-
terminus is critical for its specific deposition in the chromatin 94. The crystal structure of H2A.Z-
containing nucleosomes, along with salt-dialysis experiments, show that H2A.Z renders the 
nucleosome unstable and therefore amenable for further disruption 94. In line with this thinking, 
H2A.Z/Htz1 is present at the -1 and +1 nucleosome around the TSS, hence providing a more 
conducive nucleosome structure for transcription activation and regulation 46-48.   
Htz1/H2A.Z is incorporated in an orchestrated manner, with the help of several multi-
protein complexes such as the SWR1 and INO80 complexes 94. SWR1 is thought to be the major 
complex that regulates Htz1 deposition in yeast chromatin 94. SWR1 relies on both the direct 
binding to linker DNA 95,96 and interaction of one of its subunits, Bdf1, to hyper-acetylated 
histone H4 48,96. Bdf1 contains bromo-domains that recognize acetylated histones 48,96. This is 
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probably a major reason why Htz1-containing nucleosomes are present at -1 and +1 
nucleosomes- an area with free DNA available at the nucleosome free region (NFRs) and a hyper 
acetylated promoter. Consistent with a major role of SWR1 in depositing Htz1, loss of Swr1 or 
any of its critical subunits, results in a significant reduction in Htz1 in the chromatin 97. SWR1 
shares a number of subunits with the NuA4 complex, which is an H4-specific histone 
acetyltransferase complex (HAT)- another intriguing connection between histone acetylation and 
Htz194. In addition to the SWR1 complex, INO80 has been shown to regulate the levels of Htz1 
in the chromatin.  
 Consistent with the function of INO80 complex in regulating Htz1 levels in the chromatin, 
partial or complete loss of Ino80 results in increase in the Htz1 levels in the chromatin- in a 
manner that does not increase the total amount of Htz1 in chromatin, but rather mis-localizes 
them 37. For example, there is more Htz1 in the gene bodies and towards the 3’ end of genes in 
an inoΔ delete than in WT 37. Further analysis revealed that Htz1 eviction from specific genomic 
locations is dependent on Ino80 37, similar to the role of SWI/SNF in removing mis-localized 
Cse4 (the centromeric histone H3) 98. Additionally, two other chaperone proteins are involved in 
Htz1 dynamics- Nap1 and Chz1. Nap1 is a histone H2A-H2B and Htz1-H2B chaperone, and for 
the purposes of Htz1, it imports the Htz1-H2B dimer into the nucleus and then hands it off to 
SWR1 complex 97. In contrast, Chz1 is a Htz1-H2B specific chaperone, that has been shown to 
regulate incorporation of Htz1 in yeast chromatin 99. Both these chaperones and the dynamic 
incorporation and eviction of Htz1 will be discussed in greater detail in chapter 3. Work from 
this dissertation shows, for the first time, that Nap1 and Chz1 have non-overlapping functions in 
terms of Htz1 dynamics, interaction with Htz1-containing nucleosomes and eviction of Htz1 
from chromatin.  
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1.6 Maintenance of genomic integrity in eukaryotes:  
                Maintenance of an accurate genome is critical for the survival of any cell. Cells face a 
large number of challenges to their genome. Some of these sources of damage include intrinsic 
such as the reactive oxygen species generated from oxidative respiration while others are 
exogenous such as the ultra violet rays from the sun 100. Irrespective of the source of genomic 
insults, cells have elaborate machineries devoted to repair specific kinds of DNA damage. 
Broadly speaking, one can classify DNA damage in following classes: i) base damage ii) 
nucleotide damage iii) replication induced DNA damage and iv) DNA breaks- single- and 
double-stranded 100. Depending upon the kinds of DNA damage, cells will recruit one (or many) 
of the following pathways to repair those damages. I will describe some of these pathways, 
briefly, in the following section:  
i) Base damage- Base Excision repair, which involves removal of the mutated/altered base by a 
DNA glycosylase resulting in an abasic site. This abasic site is then cleaved by an AP 
endonuclease or an AP lyase followed by gap-filling by a DNA polymerase and ligation of the 
nick by a ligase 101.  
ii) Nucleotide damage: Nucleotide Excision Repair (NER) is the pathway of choice for fixing 
nucleotide damage to DNA 101. NER can be broadly divided into global genomic NER (GG-
NER) and transcription-coupled NER (TC-NER) 101. NER relies on identification of damaged 
nucleotides (primarily due to structural deviations in the DNA double helix) by specific 
protein(s) (Rad4-Rad23 in yeast and XPC in humans for GG-NER and elongating RNA 
Polymerase II for TC-NER) 101. Subsequently, the damaged region is accessed by general 
transcription factor, TFIIH, and XPG followed by XPA and XPF, resulting in the removal of 
about 21-23 nucleotides from the damaged region 101. DNA polymerases and ligases fill in the 
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damaged region 101. If the nucleotide damage occurs in a transcribed region, the rate of repair for 
this kind of damage is significantly faster and relies on the identification of the damage by 
elongating RNAPII 101. An additional factor (Rad26 in yeast and CSB in humans) gets recruited 
to the damaged area of the transcribed genome and results in coupling the TC-NER with GG-
NER 101.  
iii) Replication mismatches: DNA replication is intrinsically a high-fidelity process, but it can 
introduce nucleotide mismatches 102. The mismatched nucleotides, if not repaired during the 
process of replication itself, recruit the mismatch repair process. Unrepaired mismatches increase 
the mutation rates in the genome, resulting sometimes in the death of the cells 102. In addition, 
mismatches serve a useful purpose of increasing the potential for genetic variability for cells, by 
increased mutagenic potential. It is not surprising then that disruption of mismatch repair appears 
to be a favored mechanism for cancer evolution such as for colon cancer (about 50% hereditary 
non-polyposis colon cancer is due to mutations in MSH2 and MLH1 genes, that perform critical 
functions in mismatch repair) 102. Briefly, mismatch repair relies on multiple proteins that 
recognize the mismatch and excise the mismatched regions as well as components of replication 
machinery. The fundamental mechanism for mismatch repair is conserved from E.coli to 
humans, with minor details and regulatory features being different 102.  
iv) Double strand break: Double strand breaks (DSBs) in DNA are one of the most severe forms 
of DNA damage. DSBs can occur in a programmed or an un-programmed fashion 103. An 
example of programmed DSB is the generation of antibody diversity in immune cells. Another 
example is during generation of male or female gametes through the process of meiosis 103. In 
addition, cells face a wide variety of insults that can cause DSBs such as ionizing radiation and 
DSBs induced by reactive oxygen species. Generally speaking two, mutually exclusive, 
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pathways repair DSBs 103: non-homologous end joining (NHEJ) and homologous recombination 
(HR). NHEJ relies on the recruitment of yKu70-80 complex to the DSB, with the help of the 
Mre11-Rad50-Xrs2 (Nbs1) (MRX/MRN) complex 103. Recruitment of yKu70-80 results in the 
DSB ends being held together in physical proximity, in a relatively stable manner 103. The DSB 
ends can then be re-ligated after limited end processing (if necessary) by the help of additional 
NHEJ factors such as Lig4 and repair-associated DNA polymerases 103. Homologous 
recombination (HR), on the other hand, relies on the stable association of the MRX/MRN 
complex with the DSB ends 103. Such a stable association is followed by the recruitment of end-
processing factors such as Sae2 (CtIP in mammals), which promotes 5’ à 3’ exonuclease 
activity 103. Such end-processing results in resected DNA ends, a particularly preferable substrate 
for the single strand DNA binding protein, RPA 103. Subsequently, the RPA is exchanged for 
Rad51, in terms of coating ssDNA. This Rad51-DNA complex is then used for homology search, 
followed by recruitment of a vast array of other proteins that help in using the homologous DNA 
strand as a template to repair the DSB 103. The decision to use one DSB repair pathway or 
another is one of the most crucial decisions that the cell makes in terms of repairing DNA 
damage 103. This decision is based on the cell cycle stage of the cell, and availability of 
regulatory factors 103,104. If a cell is in G1-phase, due to lack of CDK1 activity and absence of an 
additional homologous copy of DNA (for haploid genomes like budding yeast), cells use NHEJ 
to repair the DSB 103,104. If the cell is in S-G2/M stage, there is ample activity of cyclin-
dependent kinases (primarily CDK1, which activates the exonuclease activity of Sae2/CtIP), 
which tilts the balance in favor of HR 103,104. In addition to the cell cycle stage, yKu70-80 acts as 
a repellent for recruitment of Sae2/CTIP to DSBs and hence inhibits HR 103,104. In mammalian 
cells, additional levels of regulation exist which depends upon 53BP1 and BRCA1 103,104. 
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BRCA1 is associated with breast cancer and 53BP1 was discovered as a p53 binding protein 105. 
It was subsequently discovered that the major function of 53BP1 is to regulate pathway choice 
after DSB in mammalian cells 105. 53BP1 gets recruited to the chromatin, depending upon the 
status of histone methylation (specifically H4K20me2) and occludes the access of BRCA1 to the 
DSB 105. BRCA1 associates with resection enzymes and thus 53BP1 inhibits the first step 
required for diverting the DBS through HR pathway 105. Recently additional factors have been 
discovered that contribute to the decision-making process after DSB. One of them is Rif1 (Rap1- 
interacting factor 1), which functions through binding to 53BP1 and inhibiting the recruitment of 
BRCA1 to the DSB, thus predisposing the DSB to be repaired by NHEJ 106-108. Inappropriate 
pathway choice can have disastrous consequences for the cell. For example, if a haploid cell 
decides to perform HR during G1 phase (like budding yeast, S.cerevisiae), it will likely end up 
using a region of the genome with poor homology and thus increase the genomic instability (due 
to strand exchange reactions that occur during HR) 103. To repair any kind of DNA damage, cells 
need to sense the DNA damage and then mount a response to repair it. This coordinated 
activation of signaling cascade is called DNA damage checkpoint, a focus of the following 
section.  
1.7 DNA damage Checkpoint Activation:  
            Once a cell’s DNA is damaged, the damage needs to be recognized by the cell and the 
appropriate signaling response needs to be activated so that the cell can repurpose the cellular 
machinery in repairing this DNA damage. Some aspects common to any kind of checkpoint 
activation involves sensing the DNA damage, recruiting signaling proteins to sites of DNA 
damage, activating a kinase cascade for effector functions and eventually regulating cell cycle 
progression and DNA repair 103,109. In eukaryotes and for double strand breaks (DSBs), the 
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process begins with the recruitment of the MRX (MRN in humans) complex to the ends of 
double strand breaks. MRX/MRN recruits the apical kinase, Tel1 (ATM in humans), in the 
vicinity of the DSB 103,109. This is followed by phosphorylation of Serine 129 (Serine 139 in 
humans) of histone H2A (H2A.X in humans) in the vicinity of the double strand break, resulting 
in what is commonly called γ-H2A.X 103,109.  From yeast to humans, γ-H2A.X acts as a 
recruitment mechanism for a wide variety of proteins including adaptor proteins and chromatin 
remodelers to modulate various aspects of DNA damage signaling and repair 103,109. Subsequent 
to the early wave of γ-H2A.X formation, resection enzymes are activated which result in 
formation of ssDNA regions 103,109. These ssDNA regions are coated by RPA and recruit and 
activate Mec1 (ATR) kinase 103,109. The activation increases the domain size of γ-H2A.X in the 
vicinity of DSB 103,109,110. In yeast, γ-H2A.X formation is followed by recruitment of Rad9, an 
adaptor protein and the yeast ortholog of 53BP1 103,109,110. Rad9 binds in the vicinity of the DSB, 
and helps in the recruitment of the effector kinase, Rad53 (Chk2 in humans) 103,109. Rad53 gets 
hyper-phosphorylated and phosphorylates Rad9 to result in full activation of DNA damage 
checkpoint and the downstream activity of Rad53 results in cell cycle arrest, transcriptional 
modulation, and regulation of DNA repair per se 103,109. Chk1 kinase plays a minor role in this 
signal transduction pathway in yeast. In humans, there are additional proteins that function in this 
entire process, such as the MDC1 protein, which acts downstream of ATM/ATR to amplify the 
DSB signaling 103,109. In all eukaryotes, aspects of DSB signaling and DSB repair are intimately 
tied to chromatin components, which will be discussed in the following section.  
1.8 Interplay of chromatin with DSB signaling and DSB repair:  
            Since all eukaryotes have their genetic material in the form of chromatin, all aspects of 
DSB repair and signaling are regulated and/or influenced by components of chromatin. This 
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includes DSB sensing, DSB processing, repair, tolerating the DSB and cell cycle progression. 
The aspects of chromatin that influence DSB signaling and repair include but are not limited to 
histone modifications, histone variants, ATP-dependent chromatin remodeling, and histone 
chaperones. The first signal of a DSB is the phosphorylation of Serine 129 of histone H2A (γ-
H2A.X, Serine 139 in human H2A.X) 103,109,110. This phosphorylation is catalyzed by a slew of 
kinases: Mec1/Tel1 in yeast and ATM/ATR and DNA-PK in human cells 103,109,110. γ-H2A.X 
influences the recruitment kinetics of DNA repair proteins, activity of resection enzymes, 
recruitment of the cohesin complex for facilitating proximity between sister chromatid during 
HR, and amplification of DSB signaling cascade 103,109,110. Given the myriad number of functions 
that γ-H2A.X is involved in during DSB response, γ-H2A.X deficient cells are sensitive to DSB 
causing agents and the γ-H2A.X-null mouse is immuno-deficient (γ-H2A.X also influences 
antibody re-arrangement) 109,110. In addition to γ-H2A.X, there is phosphorylation of other 
histone residues, such as histone H4 serine1, and H2A serine 121 that play a critical role in DSB 
signaling and repair 109,110. H4S1phos is catalyzed by casein kinase and is required for 
appropriate non-homolgous end joining of DSBs while H2AS121ph is catalyzed by Sgo1 kinase. 
H2AS121ph is required for the recruitment of the chromosome passenger complex (CPC) during 
chromosome segregation 109,110.  
         Acetylation of histones is a general signal for relaxed chromatin and it is quite well known 
that acetylated chromatin represents an ‘open chromatin’ stage. In terms of DSB signaling and 
repair, histone acetylation and deacetylation plays a critical role in pathway choice, activation of 
DSB signaling, repair of DSBs and restoration of chromatin structure after DSB repair. 
Immediately after a double strand break, deacetylation of histone H3/H4 occurs, and this is 
dependent upon the Rpd3/Sin3 deacetylase complex 109,110. This deacetylation ensures a stable 
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chromatin structure, which is more amenable for NHEJ. Similar observations have also been 
made in human cells, where HDAC1 and HDAC2 are recruited immediately to the DSB to 
deacetylate H3K56 and H3K9 so as to make the chromatin more conducive for NHEJ 111,112. In 
contrast, H4K16Ac gets induced after DSB, probably as a means of disrupting higher order 
chromatin structure and allow the NHEJ repair machinery to access the DNA 109,110. In support of 
this idea, an H4K16A mutant in yeast is deficient in NHEJ 109,110. Interestingly, the level of 
histone acetylation increases when cells switch to homologous recombination (HR). This 
includes acetylation of multiple residues of histone H4 (K5, 8, 12 and 16) and other histones as 
well, such as H2A 109,110. It is thought that this acetylation correlates with a rather dynamic 
movement of DNA in the vicinity of the DSB for the purpose of strand exchange and other 
downstream processes in HR 109,110. Consistent with this thinking, a number of histone 
acetyltransferases (HATs; such as NuA4 in yeast and Tip60 in human cells) get recruited to the 
vicinity of DSBs 109,110. Furthermore, loss of NuA4 or Tip60 activity renders the cell sensitive to 
DSB-causing agents, further providing evidence that these HATs are critical for DSB repair 
109,110.  
         Histone methylation has emerged as a major contributor to appropriate DSB signaling and 
repair in multiple eukaryotes. Histone methylation occurs on multiple lysine residues of histone 
H3 and H4. For the purposes of DSB signaling and repair, methylation of lysines 4, 9, 36 and 79 
on histone H3 and lysine 20 on histone H4 are critical 109,110. Set1 catalyzes H3K4me in yeast 
(MLL family in humans). H3K4me was shown to be crucial for DSB repair in yeast, specifically 
through the NHEJ pathway, and H3K4me3 and Set1 was observed in the vicinity of a newly 
induced DSB 109,110,113.  H3K9 methylation does not exist in budding yeast but is associated with 
heterochromatin structures in fission yeast and higher eukaryotes 109,110,113. H3K9me3 is typically 
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bound by HP1 protein and after DSB; HP1 is evicted from the chromatin (in a casein kinase 
dependent manner) allowing for the availability of H3K9me3 for other chromatin binding factors 
such as the Tip60 HAT 109,110,113. Tip60 contains an H3K9me3 binding domain and recruitment 
of Tip60 to the chromatin makes the chromatin more relaxed and allows for the appropriate DSB 
repair pathway to be recruited and repair to be accomplished 109,110,113. This coordinated 
mechanism allows for the repair of DSBs induced in heterochromatic areas. Methylation of 
histone H4 is critical for proper progression through cell cycle and regulation of DSB repair 
pathway choice. H4K20 is methylated by PR-Set7 and SUV420H1 (H4K20me1, and 
H4K20me2/3 respectively) 109,110,113. 53BP1 recognizes H4K20me2/3 and regulates DSB 
pathway repair choice. Methylation of H3K36 has emerged as a novel regulator of DSB response 
and DSB repair in yeast as well as human cells and is the focus of this dissertation (Chapter 2 
deals with the discovery that H3K36me regulates DSB response and repair in budding yeast).  
         Another way chromatin structure can be dynamically altered is by regulated incorporation 
and eviction of histone variants and activity of histone chaperones. Histone variants are altered 
versions of canonical histones that have very different biophysical properties owing to subtle 
(and sometimes quite significant) differences in amino acid sequences. In humans, the major 
sensor of DSB is γ-H2A.X, which is a phosphorylation on the histone H2A variant, H2A.X 
109,110. The incorporation of H2A.X in lieu of H2A is dependent upon the human FACT complex, 
which helps in the H2A-H2A.X exchange reaction around a DSB 109,110. Consistent with this 
phenomenon, loss of FACT complex member, SSRP in humans, result in loss of γ-H2A.X 109,110. 
In yeast however, the major H2A is H2A.X, therefore such a reaction may not exist. However, 
work from this dissertation reveals that a temperature sensitive mutation of yeast FACT 
complex, renders them exquisitely sensitive to DSB causing agents, thus establishing FACT-
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dependent histone exchange as a critical regulator of cellular response to DSB. Another critical 
histone variant that functions after DSB is the H2A variant, Htz1 in yeast (H2A.Z in humans). 
Htz1 is typically associated with the +1 nucleosome around the TSS and in the sub-telomeric 
heterochromatin 46-48. Htz1 containing nucleosomes are unstable and hence easy to disrupt 94. In 
accordance, Htz1 helps in positively regulating end-resection after DSB 109,110. Htz1 is transiently 
incorporated around a DSB and then evicted from around the DSB 109,110. This dynamic 
incorporation and eviction is critical for appropriate resection kinetics through the activity of 
both the Exo1 and Sgs1-Dna2 109,110. Consistently, htz1Δ results in diminished capacity for 
homologous recombination and reduced amplification of DSB signaling, as measured by hyper-
phosphorylation of Rad53 114. Consistent with yeast studies, H2A.Z incorporation is critical for 
the activity of CtIP and hence loss of H2A.Z from human cells renders them radiosensitive and 
incompetent in performing homologous recombination 115. Additionally, Htz1 gets modified 
(ubiquitylated and sumoylated), both of which allow an unrepaired DSB to be relocated to the 
periphery of nuclear membrane, eventually providing sufficient time for a slow DSB repair 
process to occur 114. Moreover, the major H3-H4 histone chaperone, Asf1, is required for 
acetylation of newly synthesized histones (primarily at H3K56) and their deposition in the 
chromatin once DSB repair has been accomplished. In line with this, Asf1 is required for later 
stages of DSB repair and asf1Δ cells are sensitive to ionizing radiation and DSB-inducing 
chemicals 109.  
         Large scale chromatin structure modulation, as required by DSB repair and its signaling 
pathways, necessitates the recruitment and activity of ATP-dependent chromatin remodelers. 
Therefore, deletion of critical subunits of most of the ATP-dependent remodelers makes them 
sensitive to genotoxic agents, specifically to DSB inducing agents. ATP-dependent remodelers 
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are required at almost all stages of DSB signaling and repair. For example, RSC (Remodeler of 
Structure of Chromatin) remodelers are recruited to the DSB, along with the MRX complex 109. 
This recruitment allows for disruption of nucleosome structure to facilitate MRX binding to DSB 
and subsequent stable association of yKu70-80 109. RSC is also required for recruitment of the 
cohesin complex so that sister chromatids can be in physical proximity to facilitate HR. 
Additionally, RSC functions towards the end of the HR pathway so that the nucleosome structure 
can be restored 109. Similarly, SWI/SNF in humans allows for initial chromatin remodeling and 
facilitates the recruitment of MRN-ATM and other DSB repair proteins; therefore, loss of 
SWI/SNF renders human cells radiosensitive 109. Many of these chromatin remodelers require 
interaction with various histone modifications, some of which are found and enriched around a 
DSB. This allows for a temporal and spatial regulation of multiple aspects of DSB signaling and 
DSB repair.  
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Table 2: Chapter one summary  
Regulation of chromatin structure and its influence on genome functions 
• Chromatin is a dynamic structure, which compacts the eukaryotic genome, 
and regulates a wide variety of cellular functions and processes. 
• Histones, non-histone proteins, ATP-dependent remodelers, histone variants 
and non-coding RNAs comprise chromatin and influence chromatin 
organization and function.   
• Lysine 36 methylation of histone H3 (H3K36me) and histone H2A variant, 
Htz1, are major regulators of chromatin, which the dissertation will be 
foussed on.  
• H3K36me regulates DSB signaling and repair (Chapter 2).  
• Dynamic incorporation/eviction of Htz1 is dependent on Nap1 and Chz1 
(Chapter 3). 
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CHAPTER 2: AN RNA POLYMERASE II-COUPLED FUNCTION FOR HISTONE 
H3K36 METHYLATION IN CHECKPOINT ACTIVATION AND DSB REPAIR1 
2.1 Overview 
Histone modifications are major determinants of DNA double-strand break (DSB) 
response and repair. Here we elucidate a DSB repair function for transcription-coupled Set2 
methylation at H3 lysine 36 (H3K36me). Cells devoid of Set2/H3K36me are hypersensitive 
to DNA-damaging agents and site-specific DSBs, fail to properly activate the DNA-damage 
checkpoint, and show genetic interactions with DSB-sensing and repair machinery. 
Set2/H3K36me3 is enriched at DSBs, and loss of Set2 results in altered chromatin 
architecture and inappropriate resection during G1 near break sites. Surprisingly, Set2 and 
RNA polymerase II are programmed for destruction after DSBs in a temporal manner – 
resulting in H3K36me3 to H3K36me2 transition that may be linked to DSB repair.  Finally, 
we show a requirement of Set2 in DSB repair in transcription units – thus underscoring the 
importance of transcription-dependent H3K36me in DSB repair. 
2.2 Introduction 
 Eukaryotic genomes are constantly subjected to exogenous and endogenous forms of DNA 
damage116. Double strand breaks (DSBs) can lead to temporary loss of genetic information
                                                
1 This chapter previously appeared as a shortened article in Nature Communications.  The original citation is as 
follows: Jha, D. K. et al. An RNA Polymerase II-coupled function for histone H3K36 methylation in checkpoint 
activation and DSB repair. Nat. Commun. 5:3965 doi: 10.1038/ncomms4965 (2014). 
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and failure to repair DSBs can lead to severe genome instability and cell death. DSBs can be 
programmed (e.g., meiosis and immunoglobulin rearrangements) or caused by exogenous agents 
(e.g., ionizing radiation (IR), ultra-violet 93 and anti-cancer drugs)116,117.  
In eukaryotes, chromatin plays a fundamental role in regulating the cellular response to 
DNA damage117. Among the factors that contribute to the DNA damage response (DDR) are 
histones and their post-translational modifications (e.g., phosphorylated H2A serine 129; γ-
H2A.X in metazoans), ATP-dependent chromatin remodelers (e.g., RSC, INO80, TIP60), and 
histone variants (e.g., Htz1)117. Transcription-associated histone modifications, including H3 
lysine 4 methylation (H3K4me) and H3 lysine 79 methylation (H3K79me) also contribute to 
DNA damage response and repair117. Interestingly, a majority of stalled replication sites tend to 
occur in transcribed genes118, increasing the propensity for the collision of transcription and 
replication bubbles eventually resulting in DSBs119. Yet, how the transcription apparatus 
influences DSB repair is not well understood.  
One major regulator of chromatin structure during transcription is H3 lysine 36 
methylation (H3K36me). This mark is deposited by the Set2 methyltransferase and is highly 
conserved from yeast to humans81,120-124. Set2 is recruited, at least in part, through binding to 
hyper-phosphorylated RNA Polymerase II (RNAPII) after RNAPII enters the productive 
elongation phase81,120-124. Set2 recognizes the phosphorylated C-terminal domain (CTD) of 
RNAPII through the presence of a domain called the SRI domain (for Set2-RNAPII interaction 
domain)121,122. In yeast, Set2/H3K36me regulates chromatin structure in the bodies of genes by 
activating the histone deacetylase complex Rpd3S81,83,125,126 and by regulating histone exchange 
through regulating the activity of Asf1, Chd1 and ISW1b complexes85,127.  Outside of a role for 
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Set2 in transcription elongation, much less in known regarding how this enzyme contributes to 
other DNA-templated functions. 
2.3 Results:  
2.3.1 Set2/H3K36me is required for resistance to DSB 
To test whether Set2 and H3K36me function in DNA damage repair, we assessed the 
sensitivity of yeast cells lacking SET2 to various genotoxic agents. Deletion of SET2 caused 
sensitivity to the DSB-causing agent phleomycin (an IR-mimic), mild sensitivity to the 
alkylating agent methyl methane sulfonate (MMS), but no sensitivity to hydroxyurea (HU; 
replication stress) or UV (nucleotide damage) (Fig. 2A). The phleomycin sensitivity was rescued 
by transforming the set2Δ strain with full-length SET2 (Fig. 2B). In contrast, sensitivity of the 
set2Δ strain could not be suppressed by transformation with a catalytically inactive SET2 mutant 
(SET2H199L); thus, methylation activity is required for survival after DSB (Figs. 1B and 1F). To 
further confirm the importance of Set2 in the DSB response, we utilized a strain (JKM179) in 
which a galactose-inducible, site-specific DSB in chromosome III can be repaired only by non-
homologous end joining (NHEJ)128 (Fig. 1C). Consistent with the phleomycin-sensitivity found 
with deletion of SET2, set2Δ was also sensitive to this galactose-induced DSB and was rescued 
by expressing wild-type (WT), but not catalytically inactive, Set2 (Figs. 2C, 2D and 2F). We 
ruled out the MAT-specific effect by using a strain with the HO cut site in ADH4 gene and found 
that set2Δ was sensitive to a reparable Gal- inducible DSB as well (Fig. 3A). Recently, it was 
suggested that Set2 functions in DNA damage in a catalysis-independent manner129, however 
examination of the levels of H3K36me in the presumed C201A catalytic mutant used by Winsor 
et. al revealed that it only abolished the tri-methyl form of H3K36 (Fig. 3B). Importantly, and 
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consistent with a role of Set2 methylation at H3K36 in this phenotype and DSB repair, we found 
that mutation of H3K36 (H3K36A) confers sensitivity to phleomycin (Fig. 2E).  
Set2 functions through its association with the elongating (phosphorylated) form of 
RNAPII121. We therefore asked whether the DNA damage-induced phenotype we observed in 
the absence of Set2 and H3K36me is connected to its RNAPII function. We previously 
characterized a domain in the C-terminus of Set2, termed the SRI domain, which is essential for 
coupling Set2 with the transcribing polymerase121.  Mutation of this domain uncouples Set2 from 
RNAPII and results in selective loss of H3K36me3 (Fig. 2F and130). Significantly, mutation of 
the SRI domain of SET2 (SRIΔ) could not rescue the sensitivity of set2Δ to persistent gal-
induced DSB (Fig. 2D). Taken together, these data suggest that Set2 functions in DSB repair 
through its interaction with elongating RNAPII. They further suggest the possibility that 
transcribing polymerase itself may play an important role in DSB repair – a finding that would 
be consistent with studies showing RNAPII is present at DSBs131.   
.2.3.2 SET2 is functionally connected to DSB response and repair 
To further establish that Set2 functions in cellular survival against genotoxic insults, we 
selected 30 genes representative of the pathways involved in DDR and repair and analyzed 
double mutant sensitivity to MMS. We performed our genetic interaction screen using MMS 
because of its ability to activate several DNA repair pathways as compared to phleomycin, thus 
allowing us to initially capture more possible genetic interactions between SET2 and DDR genes.  
Our screen revealed that SET2 genetically interacts (both positively and negatively) with a subset 
of DDR and repair genes, albeit to different extents (Fig. 4H).  
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Figure 2. Methylation by Set2 at H3K36 and RNAPII–Set2 interaction is 
required for cellular resistance against double strand break (DSB). Five-
fold serial dilutions of over-night cultures (grown either in YPD or 
appropriate selection medium for plasmids) were spotted on indicated plates 
and pictures were taken after 2-4 days. For immunoblots, log phase cultures 
were used for preparing whole cell lysates as described in Experimental 
Procedures. (A) A set2Δ strain is sensitive to phleomycin but not to 
hydroxyurea and UV. (B) Sensitivity of set2Δ to DSB can be rescued by wild-
type SET2 but not by a catalytically dead (SET2H199L) mutant. (C) set2Δ is 
sensitive to persistent Homothallic (HO) endonuclease-mediated DSB in the 
“donorless” strain JKM179. A schematics of the “donorless” strain is shown 
where the Gal-induced DSB is in the MAT locus of chromosome III. This 
strain has the HML and the HMR deleted and hence the DSB can be repaired 
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only by NHEJ. (D) Rescue of set2Δ sensitivity to persistent DSB by wild-type 
SET2 but not by a catalytically dead (SET2H199L) or the SRIΔ mutant. (E) 
H3K36A phenocopies set2Δ on phleomycin. (F) Immunoblots showing the 
expression from the constructs used in Figs 1B and 1D. 
 
 
 
Figure 3. set2Δ is sensitive to persistent but reparable DSB at ADH4 locus and set2Δ does 
not alter yKu80 protein levels. (A) set2Δ are sensitive to persistent and reparable DSB at the 
ADH4 locus. (B) C201A has significantly higher amounts of H3K36me2 and H3K36me1 as 
compared to H199L. (C) Deletion of SET2 does not alter yKu80 protein levels. The arrows 
indicate the time of galactose-induction. The numbers below are yKu80/G6PDH ratio. 
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In addition to recapitulating some prior genetic interactions (e.g., between SET2 and 
SLX5) reported by the Idekker group132, we discovered several novel genetic interactions upon 
MMS treatment (e.g., RAD9 and RAD51) (Fig. 4H). We focused on DSB-specific genes and 
repeated the genetic interactions using phleomycin (examples shown in Fig. 4A, B, C and F). 
Interestingly, the set2Δrad9Δ double mutant was more sensitive to MMS and phleomycin than 
either single mutant alone, suggesting that Set2 functions in parallel to Rad9, to provide 
resistance to DSB (Fig. 4C). Like the set2Δ single mutants, the set2Δrad9Δ synthetic sickness 
was rescued by WT SET2, but not by a catalytically- dead version of SET2 (SET2H199L) (Fig. 
4C). These results agree with similar findings recently reported in a high-throughput genetic 
interaction map using multiple genotoxic agents133.  
Because Set2 antagonizes the histone chaperone Asf1 to regulate histone exchange 
during transcription elongation85, we also asked whether the sensitivity of set2Δ might be due to 
mis-regulated histone exchange after DSB. To test this, we analyzed the asf1Δset2Δ double 
mutant on phleomycin. However, the double mutant was synthetically sick on phleomycin (Fig. 
4G), indicating that Set2 is required for survival in the absence of Asf1 after DSB. Our data 
show that in regards to DSB, Asf1 and Set2 have independent functions.  
Since Set2/H3K36me is a histone modification associated with transcription elongation, 
we wondered whether any of the genetic interactions observed might be an indirect consequence 
of transcriptional alterations.  However, transcription is only mildly affected in set2Δ134,135, and 
most of the changes are relatively modest increases in gene expression135.  Notably, only a 
handful of genes are down-regulated in set2Δ and do not include any canonical DDR or repair 
genes. Consistent with this, the gene expression and pathway analysis performed by Lenstra et 
al. showed that set2Δ do not cluster with processes related to DDR and repair135. Additionally, 
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we asked whether the protein levels of an early DSB response factor might be altered in set2Δ.  
We found no significant change in the proteins levels of yKu80, before or after DSB (Fig. 3C). 
Thus, the specific sensitivity of set2Δ to DSB-causing agents is not attributable to an indirect 
effect of gene expression changes. 
2.3.3 Set2/H3K36me regulates checkpoint activation after DSB 
To determine if the sensitivity of set2Δ was due to defective DNA-damage signaling, we 
exposed asynchronous cultures of WT and set2Δ strains to either MMS (M) or phleomycin (P) 
and monitored activation of γ-H2A.X (or H2AS129ph) and Rad53 (yeast homolog of 
mammalian Chk2). We observed reduced levels of Rad53 activation and γ-H2A.X in set2Δ, 
suggesting attenuated DSB damage response signaling (Figs. 5A, 5B and 6B). Deletion of SET2 
in the evolutionarily divergent yeast species Schizosaccharomyces pombe also resulted in 
reduced H2AS129ph when exposed to phleomycin (Fig. 6A).  
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Figure 4. SET2 functionally interacts with DNA damage response and repair genes. (A) 
Representative serial dilution growth assays for some of the single mutants (yfgΔ) and double 
mutants (yfgΔset2Δ) on MMS and phleomycin. (B) set2Δ is epistatic to yku70Δ on phleomycin 
induced DNA damage. (C) Wild-type but not a catalytically dead (SET2H199L) Set2 can rescue 
synthetic sickness of rad9Δset2Δ to MMS. (D) None of the known effector proteins, downstream 
of H3K36me, phenocopied the sensitivity of set2Δ on phleomycin. (E) H3K36me functions in a 
pathway parallel to H3K56R after phleomycin-induced DSB. (F) set2Δ is synthetic sick to htz1Δ 
and swr1Δ on phleomycin. (G) set2Δ is synthetic sick with deletions of HR machinery such as 
rad51Δ and histone chaperone asf1Δ while epistatic to yku70Δ and dot1Δ on phleomycin induced 
DNA damage. (H) Summary of the entire genetic screen, with functional processed the 
corresponding genes are involved in. 
 
γ-H2A.X activation is one of the earliest steps after DSB-induction and occurs with 
extremely fast kinetics136. To determine if this reduced level of γ-H2A.X was due to inefficient 
activation or faster de-phosphorylation (which normally occurs later in the DDR pathway)137, we 
monitored the activation of γ-H2A.X after DSB-induction by phleomycin. We observed 
significantly lower levels of γ-H2A.X within the first hour of phleomycin treatment of set2Δ 
cells (Fig. 5C), implying a function for Set2 at an early step after DSB. Additionally, and in line 
with reduced activation of DNA damage checkpoint, Rad53 hyper-phosphorylation was severely 
reduced in a set2Δ strain in a similar time-scale (Fig. 5D). Importantly, we found Rad53 
activation was also reduced in a H3K36A strain (Fig. 5E). Taken together, our data show that 
Set2-mediated H3K36me is essential for maximal activation of the DNA damage checkpoint 
after DSB induction.  
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Figure 5. DNA damage signaling is attenuated in set2Δ. Log-phase cells were exposed to 
phleomycin for indicated times and whole cell extracts were prepared (see Methods). (A) 
Diminution in Rad53 hyper-phosphorylation at indicated time-periods in a set2Δ after 
phleomycin treatment. The antibody to Rad53 is against the protein and G6PDH is used as a 
loading control. (B) Abrogated γ-H2A.X activation in set2Δ after phleomycin (50 µg/mL) 
treatment for two hours. (C) Time-course showing the activation of γ-H2A.X after 
phleomycin treatment. Quantification (H2AS129ph/H2A) of the western blot shown in Fig 
3C. (D) Full activation of Rad53 was monitored after phleomycin treatment in WT and 
set2Δ. Quantification (Rad53/G6PDH) is plotted below the blot, which shows abrogated 
DNA damage checkpoint activation (semi-log plot). (E) H3K36A mutant cells also show 
abrogated DNA damage checkpoint activation as monitored by Rad53 activation kinetics. 
 
  
 
Figure 6. set2Δ leads to reduced DNA damage checkpoint activation. (A) set2Δ leads to 
attenuated activation of γ-H2Ax after phleomycin (500 µg/mL) treatment for 2 hours in 
Schizosaccharomyces pombe. (B) set2Δ leads to attenuated activation of γ-H2Ax after MMS 
and phleomycin for 2 hours in Saccharomyces cerevisiae. 
 
2.3.4 H3K36me2 and me3 are DSB-inducible and present at DSBs 
Because the catalytic function of Set2 is responsible for providing resistance to DSBs 
(Fig. 2) and full activation of DDR (Figs. 5 and 6), we next determined if the levels of 
H3K36me change after induction of DSB. We induced DSBs using phleomycin in an 
asynchronously growing culture and monitored H3K36me3 levels by Western blot analysis. 
Interestingly, H3K36me3 levels increased globally within an hour after exposure to phleomycin 
and then returned to basal levels (Fig. 7A). In contrast, H3K36me2 increased with much slower 
a
WT set2¨
(S. pombe)
– + – +
H2AS129ph
H2A
17kDa
17kDa
H2AS129ph
H2A
WT set2¨
–     M     P –     M     P
0.03   5.33  11.20  0.06   1.33    3.88H2AS129ph/H2A
17kDa
17kDa
b
  
 40 
kinetics (Fig. 7B) and reached its highest levels at a later time-point (i.e., 4-5 hours after 
phleomycin treatment). Although it is possible that the increase in H3K36me2 at the later time-
point was an active response to DSB, the increase coincided with the decrease in H3K36me3 – 
suggesting a specific loss of H3K36me3 to form more H3K36me2. To further verify that we 
were monitoring a DSB-inducible histone modification, we examined the levels of H3K36me3 
near the site of DSB (0.2 kb distal to the DSB in the MAT locus) at early time-points to 
accurately capture a transient induction. H3K36me3 was increased, although modestly, within 30 
minutes of galactose-induced DSB and tapered off approximately 75 minutes after DSB 
induction (Fig. 7C). This degree of increase is in line with the changes reported for H4 
acetylation around the DSB138,139. Consistent with global H3K36me2 levels measured by 
immunoblot (Fig. 7B), ChIP analysis indicated that H3K36me2 was induced at a later time point 
than H3K36me3 (Fig. 7D). Further, we detected an enrichment of Set2 at the DSB at an early 
time-point following DNA damage (Fig. 7E). The specificities of our H3K36me3, H3K36me2 
and Set2 antibodies were confirmed by inclusion of a set2Δ sample (Figs. 7A-E and Fig. 8). 
Collectively, our data indicates H3K36me3 is DSB-inducible and transitions into H3K36me2 – a 
finding which coincides with transiently enriched Set2.  
To further understand the molecular basis for the temporal regulation of H3K36me2 and 
H3K36me3, we monitored the global levels of Set2 following DNA damage. Upon MMS and 
phleomycin treatment, we found that Set2 protein levels were significantly decreased (Fig. 7F). 
Surprisingly, we also noticed that the levels of Rpb1 (the largest subunit of RNAPII), and 
consequently the Ser2 phosphorylated form of RNAPII CTD (Ser2p CTD), also degraded after 
DNA damage in a proteasome-dependent manner (Fig. 7F and Figs. 8B, 8F). Collectively, these 
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results reveal a programed destruction of Set2 and RNAPII after DSB, which may be an 
important event in DSB sensing and repair.  
To monitor if we see a similar reduction in the levels of RNAPII in the vicinity of a DSB, 
we did ChIP analysis for RNAPII around the MAT DSB. Consistent with the presence of Set2, 
we see RNAPII to be present at the same locus. Additionally, after 30 minutes of DSB induction, 
we can see significant reduction in the level of RNAPII (Fig. 8G), a result consistent with our 
global analysis. To our knowledge, this is the first demonstration of proteasome-dependent 
regulation of RNAPII after DSB in any model system.  
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Figure 7. Temporal regulation of H3K36me3 and H3K36me2 is driven by regulated down-
regulation of Set2. Immunoblots showing the levels of (A) H3K36me3 and (B) H3K36me2 
after DSB induction by phleomycin. Exponentially growing yeast cells were exposed to 
phleomycin for indicated times and whole cell extracts were prepared. (C) H3K36me3 is 
transiently induced near the site of DSB (assessed by ChIP at 0.2 kb), at early time-points. The 
error bars represent ± s.e.m from two different biological replicates. n.m represents ‘not 
measurable’ (D) H3K36me2 is induced near the site of DSB (assessed by ChIP at 0.2 kb), at 
later time points. The error bars represent ± s.e.m from two different biological replicates. n.m 
represents ‘not measurable’ (* represents p <0.05 for 4C and 4D). (E) Preferential enrichment 
of Set2 near DSB (assessed by ChIP at 0.2kb from DSB). n.m represents not measurable (*** 
represents p<0.01). (F) Time course experiment after phleomycin treatment for Set2 (FLAG-
Set2), Ser2pCTD (elongating RNA Polymerase II) and Rpb1 (largest subunit of RNAPII). 
G6PDH is used as loading control.  
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pS/T-phosphorylation (a mark commonly associated with phosphorylation-dependent 
degradation140) concomitant with reduced Set2 levels (Fig. 8D). While Set2 degradation is likely 
attributed to loss of RNAPII interaction, an alternate hypothesis could be that Set2 is targeted for 
phosphorylation- dependent degradation in a checkpoint-dependent manner after DSB.  
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tested (Fig. 8E). These data show that in WT cells, Set2, RNAPII and H3K36me are regulated 
after DSB, consistent with a role for Set2/H3K36me in regulating cellular resistance to DSB.  
 
2.3.5 Interplay between Set2 and chromatin regulators after DSB  
Our genetic and biochemical evidence suggests that Set2 has a methylation– and 
RNAPII–dependent function after DSB. Set2-catalyzed H3K36me modulates chromatin 
structure via activation of the Rpd3S histone deacetylase complex81,83,125,126, antagonizing the 
function of Asf185 and regulating ISW1b function127. Thus, we investigated whether any of these 
pathways contribute to the function of Set2 after DSB. As mentioned above, the asf1Δset2Δ 
double mutant is synthetically sick on phleomycin, suggesting that Set2 and Asf1 function in 
parallel after DSB (Fig. 4G). Consistent with this finding, we also noticed synthetic sickness of 
H3K36A with H3K56R (H3K56Ac being a marker of histone exchange) on phleomycin (Fig. 
4E). To test the other possible H3K36me effector proteins, we deleted RCO1 (Rpd3S-specific 
subunit), IOC4 (Isw1b-specific H3K36me effector protein) and YLR455w (a PWWP-containing 
putative H3K36me binder) and determined if any of these strains phenocopied set2Δ. None of 
these known or putative H3K36me effector proteins showed similar phleomycin sensitivity as 
set2Δ in isolation (Fig. 4D). Whether specific combinations of these effectors are required or if a 
novel effector protein is reading H3K36me remains to be determined.  
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We next investigated other histone modifiers known to play a role in the DDR, Dot1 and 
the histone variant Htz1. Dot1-dependent H3K79 methylation (H3K79me) and Htz1 are two 
chromatin components that are crucial for DSB response and repair141-146. H3K79me modulates 
the DSB checkpoint response by recruiting or stabilizing the Rad9 adaptor protein on 
chromatin146,147 and inhibits DSB end-resection in a Rad9-dependent fashion148,149. Htz1 has 
been implicated in a multitude of events occurring after DSB. We investigated the genetic 
interactions between SET2 with DOT1 and HTZ1 to determine whether Set2 is part of any of the 
known pathways (or processes) in which these proteins function after DSB. We observed that 
set2Δ was synthetically sick with htz1Δ and swr1Δ (Fig. 4F), but set2Δ suppressed the mild 
resistance of dot1Δ to phleomycin (Fig. 4G).  These data reveal that Set2/H3K36me is required 
for cell survival in the absence of Swr1/Htz1 function. They also suggest that Set2 and Dot1 
might function in antagonistic manner to regulate cellular response to DSB. 
 
Figure 8. Regulation of Set2 and Rpb1 after DSB. (A) Set2 is regulated after MMS and 
Phleomycin induced DNA damage. (B) Ser2 pCTD and Rpb1 are down-regulated after MMS 
and Phelomycin induced DNA damage. (C) FLAG-M2 or HA-7 (beads against the HA tag) 
beads were used to immunoprecipitate Set2-FLAG from an untagged (BY4742) and Set2-
3XFLAG strains and immunoblotting was performed with indicated antibodies. IP’s with 
untagged BY4741 strain, HA-7 beads (beads with monoclonal antibody against HA tag) were 
performed to confirm the specificities to FLAG tag and the FLAG- M2 beads respectively. 
Additionally, G6PDH immunoblot was done on the IP samples to confirm the specificity of the 
pull-down. (D) FLAG-Set2 was immunoprecipitated at indicated time-points after phleomycin 
treatment and blotted for either FLAG or pS/T-P antibody. The input western blot for the IP is 
shown in Fig. 4F. (E) RNA Polymerase II gets degraded after DSB in a proteasome-dependent 
manner. MG-132 addition to the phleomycin-treated samples prevents Rpb1 degradation. (F) 
4H8 antibody to RNA Polymerase II was used to chip Rpb1 at 0.2kb after DSB induction. 
Within 30’ after DSB induction, Rpb1 IP signal is reduced.  (*** represents p<0.01 from at 
least 2 independent biological experiments). 
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2.3.6 Set2 regulates chromatin dynamics around a DSB  
Based upon synthetic sickness of set2Δ with genes involved in homologous 
recombination, early abrogation of DNA damage checkpoint and sensitivity to ‘error-prone 
NHEJ’ (as revealed by persistent DSB in JKM179 ‘donor-less’ strain) (Fig.2C), we investigated 
if the early steps of chromatin remodeling might be defective in cells deleted for SET2. Thus, we 
induced DSB (in asynchronous cultures) by galactose treatment in the JKM179 donor-less strain 
and performed a time-course-based ChIP experiment for histones, their post-translational 
modifications and histone variants, at regions near the DSB and at an unrelated locus (ARS315) 
as a control. We monitored the DSB induction kinetics, using primers across the induced DSB, in 
WT and set2Δ and found that to be identical (Fig. 9A). We also confirmed the reduced DNA 
damage checkpoint activation in set2Δ by monitoring γ-H2A.X around a DSB. Consistent with 
previously published results for γ-H2A.X around a DSB, we observed a rapid accumulation of γ-
H2A.X within an hour of DSB induction. In contrast, set2Δ showed no significant γ-H2A.X 
activation (Fig. 9C).  
After a DSB, an early response of WT cells is to ensure a de-acetylated chromatin state, 
thereby enabling NHEJ in yKu70-80-dependent fashion150-153. Removal of yKu70-80, due to 
activation of Sae2 (and other resection enzymes) results in DSB being processed for homologous 
recombination153, which correlates with increased acetylation of histones138,139. Consistent with 
previously published results for H4 acetylation150, in WT cells, H4 acetylation decreased early, 
followed by an increase in H4 acetylation (Fig. 9D, solid line, at 0.2kb away from DSB).  In 
contrast, H4 acetylation was significantly higher in set2Δ cells compared to WT cells around 1.5 
hour after gal-induced DSB (Fig. 9D, dashed line). Notably, the subsequent increase in H4 
acetylation seen in WT cells did not occur in set2Δ cells (Fig. 9D, dashed line), indicating that 
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the dynamic changes in H4 acetylation that normally occur after a DSB were altered in the 
absence of Set2 – a result consistent with the idea that chromatin structure at DSBs is influenced 
by Set2 and H3K36me.  Because NuA4 drives, in large part, H4 acetylation at DSBs, the altered 
H4 acetylation seen in set2Δ cells may have been due to altered NuA4 activity (a result also 
consistent with the finding that NuA4 function is partially depended on H3K36me154).  
Given the observed changes in H4 acetylation, we next looked at Htz1, an H2A histone 
variant that is deposited at DSBs by the SWR1 complex, which recognizes acetylated 
histones47,48,155.  Consistent with published literature, Htz1 levels decreased in the vicinity of the 
DSB in WT cells (Fig. 9E)117.  In contrast, there was more retention of both Htz1 and H3 around 
the same DSB in set2Δ cells (Figs. 9E and 9B). The level of Htz1 was not altered globally (Fig. 
9I). Aberrant retention of Htz1-containing nucleosomes around the DSB reduces the available 
biochemical pool of substrate for Tel1 (i.e., H2A) and this may provide a molecular basis for the 
defects in the DNA damage checkpoint that is observed in the absence of Set2 (i.e., reduced γ-
H2A.X), although we formally do not rule out an abrogated activation of Tel1 as a molecular 
explanation. However, a similar antagonistic relationship has been observed in the case of 
ino80Δ (chromatin remodeling complex required for removing Htz1 from chromatin), where 
increased retention of Htz1 reduces γ-H2A.X 143.  
 Given the critical role nucleosomal architecture plays in DSB response and the known 
role of FACT, a major regulator of nucleosome structure, in cellular resistance to DSBs in 
mammalian cells156, we next investigated if SET2 functionally interacts with the FACT complex. 
Interestingly, the Spt16 subunit of FACT regulates H2A.X exchange at DSBs in human cells, 
indicating that FACT regulates nucleosome dynamics at DSBs.  In yeast, mutants of Spt16 (e.g., 
spt16-11) are sensitive to replication stress and high temperature and significantly, are 
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suppressed by deletion of SET2157,158.  We therefore reasoned that FACT mutants may be 
sensitive to genotoxic agents and this genotoxic sensitivity would be suppressed by set2Δ.  As 
shown in Fig. 9J, we found that the spt16-11 allele was extremely sensitive to phleomycin at 
permissive temperature.  Consistent with the idea that Set2 opposes the action of FACT 
function158, deletion of SET2 suppressed, albeit partially, the DSB sensitivity of the spt16-11 
strain.  These data suggest the intriguing possibility that Set2 and FACT have opposing effects 
on nucleosomal dynamics at DSBs.  
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Figure 9. Set2 regulates chromatin remodeling after DSB induction. (A) The DSB 
induction kinetics is identical in WT and set2Δ. (B) Increased H3 retention in set2Δ after gal-
induced DSB at 0.2kb around DSB. Error-bars represent s.e.m from 2 independent biological 
replicates. * refers to p< 0.05 (2-tailed t-test). (C) Reduced γ-H2A.X levels in set2Δ by chip. 
(** represents p<0.03; error bars show ± s.e.m. from two independent biological replicates)  
(D) Altered kinetics of H4Ac4 at 0.2 kb from the DSB in set2Δ at indicated time points (** 
represents p <0.03 and *** represents p<0.01; error bars show ± s.e.m. from two independent 
biological replicates) (E) Increased Htz1 levels at 0.2 kb from the DSB in set2Δ (error bars 
represent mean ± s.d. from two independent biological replicates). (F) Increased loss of input 
DNA in set2Δ in G1-arrested cells at 1kb away from the DSB and increased recruitment of 
RPA in a G1-arrested set2Δ cell (H) but not the wild type (G). (** represents p <0.03 and *** 
represents p<0.01; error bars show ± s.e.m. from two independent biological replicates). (I) 
No discernible change in whole cell levels of Htz1 in a set2Δ – with or without phleomycin. 
(J) set2Δ can partially suppress the genotoxic sensitivity of spt16-11 strains. 
 
2.3.7 Set2 regulates DSB repair in the context of transcription 
We next asked what the functional consequence of losing Set2 and H3K36me would be 
on DNA repair and repair pathway choice. Our data show that loss of Set2/H3K36me results in 
aberrant retention of Htz1-containing nucleosomes at DSBs, suggesting an unstable nucleosome 
architecture around these regions since Htz1-containing nucleosomes result in less stable 
nucleosomes159.  Importantly, a recent study showed that Htz1-containing nucleosomes aid in 
Exo1-dependent end-resection160.  
We therefore used the input DNA from our cycling cells and monitored the loss of input 
DNA (as a surrogate readout of end resection). We did not detect any difference in the rate of 
set2ǻ
W303
spt16-11
spt16-11set2ǻ
YPD 1 ȝg/mL Phleomycin
j 
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input DNA loss compared to that of set2Δ cells (data not shown). However, end-resection is 
heavily influenced by the cell cycle (G1 vs. G2/M), and smaller differences in resection kinetics 
may not become apparent in cycling cells. Therefore, we arrested cells in G1 by α-factor and 
monitored the loss of input DNA. In WT cells, we did not see any significant loss in input DNA, 
but, in set2Δ cells, the input DNA was rapidly lost, suggesting that set2Δ cells show faster end-
processing in G1-arrested cells – a time when resection is normally suppressed (Fig. 9F). We 
confirmed this by monitoring the enrichment of single-strand DNA binding protein, RPA, in G1-
arrested cells. We observed that even within 30 minutes after DSB induction, there is more RPA 
around a DSB in a set2Δ as compared to WT (Fig. 9G and 9H). This effect is likely a direct 
consequence of having more Htz1-containing nucleosomes in a set2Δ as well as reduced γ-
H2A.X, which is known to be inhibitory to resection149.  
One prediction from this observation would be that Set2 should regulate non-homologous 
end-joining (NHEJ), and in the absence of Set2, one should see lower end-joining efficiency. A 
canonical assay used to monitor the efficiency of end-joining is the calculation of the ratio of 
colony numbers obtained after transformation of linearized plasmids to that obtained from 
transforming a circular plasmid (i.e., re-ligation efficiency). Using a plasmid where we generated 
a blunt-end cut in the plasmid multiple cloning site, we observed that there was no difference in 
the re-ligation efficiency between WT and set2Δ strains (Fig. 10A). However, since Set2 
functions in the context of transcription units, we hypothesized that the function of Set2 in DNA 
repair would be more evident if our cut site was in the context of a gene body. We therefore 
carried out the plasmid re-ligation assay again, but in this case, with the cut site within the LacZ 
gene body. Strikingly, we observed a significant increase in plasmid re-ligation efficiency in 
set2Δ strains (Fig. 10B).  We take these results to mean that although Set2 regulates pathway 
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choice with a likely preference towards promoting NHEJ, the loss of Set2 does not completely 
ablate this function – hence, some plasmid would be re-ligated that would then serve as a 
template for ensuing HR as the balance has been tilted to this pathway.  Importantly, HR is a 
canonical mechanism of repair in transcription units161,162, which would further exacerbate the 
set2Δ phenotype resulting in more re-ligation. 
We next asked if this increased re-ligation efficiency is indeed a consequence of more 
recombination events, presumably due to transcription161. To answer that question, we deleted 
RAD51 in set2Δ and monitored the re-ligation efficiency. Consistent with the idea proposed 
above, we observed that the increase in plasmid re-ligation efficiency in a set2Δ was suppressed 
by deletion of RAD51 (Fig. 10B), indicating that set2Δ cells exhibit increased HR. To investigate 
if this effect was specific for the type of DSB induced, we used another restriction enzyme (SacI) 
that creates staggered ends, again in the context of transcription. Even in this context, we 
observed higher plasmid re-ligation efficiency in set2Δ strains (Supplementary Fig. 10C). This 
phenotype of set2Δ is reminiscent of rsc and sth1 mutants, where linearization of the plasmid by 
digestion in a transcription unit resulted in higher re-ligation efficiency than wild-type cells163. 
Although the precise mechanism of increased re-ligation efficiency is not yet understood, these 
results reinforce the idea that Set2/H3K36me plays an important role in DSB repair, especially in 
the context of transcription. 
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Figure 10. Set2 primarily functions in DSB repair in the context of a transcribing unit. (A) 
Linearized (SmaI) or circularized pRS316 plasmids were transformed, in parallel, into the 
indicated strains and colony numbers were counted after 2-3 days on Sc-Ura plates. Religation 
frequency was calculated as the ratio of the number of colonies obtained from linearized plasmid 
to the number colonies obtained from circularized plasmid, with the value for WT strain 
normalized to 1.0. yku70Δ is the positive control for the assay. (B) Linearized (SmaI) or 
circularized pGV255-live plasmids were transformed, in parallel, into indicated strains and 
number of colonies were counted after 2-3 days on Sc-Ura plates. Religation frequency was 
calculated as above. (** represents p< 0.02; error bars represent standard deviation from 3 
different independent transformation experiments). (C) Same as figure 10.B except that SacI was 
used as the enzyme to induce the DSB. (* represents p< 0.05; error bars represent standard 
deviation from 3 different independent transformation experiments). 
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Figure 11. A simplified model depicting a function of Set2 and H3K36me in regulating 
DNA damage response and repair. Immediately after DSB (shown as ‘lightning bolt’), Set2-
dependent H3K36me3 becomes enriched around the DSB. Increased H3K36me3 ensures a de-
acetylated chromatin structure to prevent inappropriate DNA transactions especially in the 
context of a transcription unit, which we propose is important for maintaining the genomic 
integrity of transcribing units. Consistent with this model, loss of Set2/H3K36me leads to 
abrogated DNA damage signaling activation, altered chromatin structure, and inappropriate 
repair.  
 
Repressive Chromatin!
WT!
HR!
G1!
Genome Maintenance!
Open Chromatin!
G1!
HR!
Genome Instability!
set2Δ"
Ht
z1
Set2
RNAPII
P
P P
Ht
z1
Set2
RNAPII
P
P
P
Set2
RNAPII
P
Ht
z1
Me Me Me
P
P
Ht
z1
RNAPII
P
P P
Ht
z1
RNAPII
P
P P
Ac Ac Ac
Ht
z1
RNAPII
P
Ht
z1
  
 55 
2.4 Discussion  
In this article, we provide genetic and biochemical evidence that Set2, and its methylation 
at H3K36, functions at an early step after DSB and plays a role in DSB repair. Specifically, we 
find Set2/H3K36me is critical for proper DSB checkpoint activation and impinges on pathway 
choice—results that can be linked to its function with elongating RNAPII. The role of 
Set2/H3K36me in DDR and repair is likely to maintain appropriate chromatin structure at break 
sites, which impinges on the molecular events that occur during DNA repair. 
Our data provide a temporal picture of how Set2 and H3K36me might modulate 
chromatin structure after a DSB. Using time-course immunoblotting and ChIP, we found that 
loss of Set2 leads to reduced γ-H2A.X, increased acetylation of H4 and aberrant retention of H3 
and Htz1 at break sites. We propose that this altered chromatin architecture underlies the 
increased end-resection observed in G1-arrested cells, suggesting that HR is activated sooner in 
set2Δ at G1. Additionally, we found that loss of Set2 leads to increased HR, when a DSB is in 
the gene body. Future experiments will be required to determine whether H3K36me3 or 
H3K36me2 plays an important role in recruiting any DSB repair factors to control repair 
pathway choice, in a cell-cycle and/or transcription-dependent manner. Although H3K36me2 
affects Ku70-80 recruitment to DSB in human cells54, such recruitment appears not to occur in 
cycling yeast cells as we did not see any significant alterations in Ku80 recruitment in set2Δ 
(data not shown). We found that Set2 and RNAPII are programmed for destruction after DSBs in 
a proteasome-dependent manner, which correlates with a transition of H3K36me3 to H3K36me2 
(Fig. 7 and 8). Although the function of this transition in DSB repair is not yet known, we 
hypothesize that this methyl-state transition after DSB functions to ensure a chromatin structure 
that is temporally ‘tunable’ for DSB repair. We speculate that the fine-tuning of chromatin 
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structure via H3K36me states would come from the ability of these different methyl states to 
activate/regulate functions of HATs and HDACs55. 
With regards to Htz1, the dynamic level of Htz1 around a DSB is critical for multiple 
steps in the response to DSB. Intriguingly, both in vivo and in vitro, H3K36me3 and Htz1 are 
mutually exclusive56, 57; hence, one function of an early increase in H3K36me3 at sites of DSBs 
could be to prevent Htz1 deposition, thereby allowing more H2A (H2A and Htz1 being mutually 
exclusive in chromatin) to be phosphorylated to form γ-H2A.X domains. Consistent with this 
idea, we observed increases in Htz1 and lower γ-H2A.X in a set2Δ (Figs 5 and 9). 
Our study found that Set2’s function in DDR and repair is dependent on its association 
with elongating RNAPII (Fig. 2). Consistent with this, we observed that when a DSB is in the 
context of transcription, deletion of SET2 leads to an increase in HR events (Fig. 10). This result 
might be explained by the fact that Set2 loss tips the balance away from NHEJ to HR, which can 
be a preferred mechanism for break site repair in transcription units. We speculate that Set2-
dependent chromatin compaction in G1 aids in preventing HR events, which would further 
prevent inappropriate recombination events that would arise in genes at this point in the cell 
cycle. It is also interesting to note that Set2/H3K36me is correlated with transcription rates and 
gene lengths15, which might fine-tune the appropriate type of repair that would occur in genes 
undergoing distinct rates of transcription. 
The dependence of Set2/H3K36me for proper repair in gene bodies provides further 
evidence for an RNAPII-dependent DNA damage-sensing mechanism. Lindsey-Boltz and 
Sancar58 postulated the existence of such a DNA damage ‘sensor’ due to the extremely slow off-
rate of RNAPII on DNA. Consistent with this idea, studies (including these herein) have found 
RNAPII at sites of DSB in yeast (and mammals)19 and NuA4 and other chromatin modifiers that 
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associate and function at DSBs are also associated with RNAPII2. In mammalian cells, DSB 
induces local chromatin silencing if the DSB is in a gene body. We surmise that the transcription 
machinery can be ‘co-opted’ by the DNA repair and signalling machinery to sense DNA damage 
and then use the already available chromatin modifiers (ATP-dependent remodellers/histone 
variants) to access and repair the damage, followed by restoration of the chromatin structure. 
This scenario would be especially useful during gene transcription induced R-loop formation, 
which can result in single or double-strand breaks59. Interestingly, both transcription and DSBs 
result in fairly identical mitotic recombination events52, making the possibility of RNAPII as a 
‘constitutive DSB sensor’ even more plausible58. Given the stochastic nature of transcription60, 
using the transcription apparatus as a sensor for DNA damage can be a useful strategy for cells to 
rapidly respond to exogenous or endogenous genomic insults. Consistent with this model, a 
recent paper by the Legube group61 shows that transcription units preferentially shunt the DSB to 
HR-dependent pathways. This phenomenon also was dependent upon the presence of the 
mammalian Set2 homologue, SETD2, and the presence of H3K36me3. We speculate that the 
DSB repair machinery can utilize the context-dependent chromatin environment to access and 
repair the DSB and maintain genome integrity. 
Finally, the conservation of H3K36me across different species lends credibility to the 
idea that H3K36me is also important for DSB repair and damage response in other organisms. 
Indeed, Tim Humphrey’s group62 has discovered that the S. pombe Set2 also regulates pathway 
choice, because deletion of SET2 alters the balance between NHEJ and HR. Interestingly, they 
find that Gcn5 acetylates H3K36 (ref. 63) when Set2 is absent, and this activity leads to 
increased HR by presumably making the chromatin more accessible to the HR pathway. 
Additionally, Fnu et al.54 showed that H3K36me2 catalysed by SETMAR/Metnase, which is not 
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a canonical H3K36 methyltransferase, is critical for NHEJ in human cells. Taken together, we 
propose Set2 as a key player in the DNA repair pathway that likely impinges on genome 
stability. As human SETD264 is mutated in a variety of cancers65, we speculate that SETD2 has a 
conserved role in DNA repair that would explain its connection to human disease. 
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2.5 Methods 
Yeast strains and plasmids 
All strains, unless otherwise stated, were in the BY4741 background. The strain for GAL-
inducible HO endonuclease (JKM179) was obtained from James Haber, Brandeis University and 
subsequent gene deletions (SET2 and YKU70) were performed by gene replacement using the 
PCR tool kit. The strains are listed in Table 6. 
Plasmids expressing SET2 from its own promoter were obtained from Scott Briggs (Purdue 
University) and the H199L mutation was made in full-length SET2 by site-directed mutagenesis 
(Quikchange, Stratagene). 
DNA damage sensitivity assays 
Cultures grown overnight were diluted to an OD600 of 0.25, fivefold serially diluted and 
spotted on plates with or without relevant drugs. For UV experiments, cells were spotted on 
control plates and exposed to a range of UV dosage (from 20–60  J  m−2 in Stratagene crosslinker 
P1800, rad4Δ served as a positive control for sensitivity to UV). For GAL-inducible DSB, 
overnight grown cells were serially diluted (starting ODs of between 2 and 5) as indicated above 
and spotted on Sc-Ura plates containing either 2% dextrose or 2% galactose. Pictures were taken 
after 2–4 days. For liquid culture experiments, log phase cultures were exposed to phleomycin 
(250  µg  ml−1 except for Fig. 4b, wherein 50  µg  ml−1 was used to test whether the phenotype was 
due to a high concentration of phleomycin) for indicated times, and then extracts were prepared 
by SUMEB method. About 5 O.D equivalent of cells were taken and lysed by bead beating using 
the lysis buffer containing (1% SDS, 8  M urea, 10  mM MOPS, pH 6.8, 10  mM EDTA, 0.01% 
bromophenol blue). In all, 200  µl of buffer with 200  µl equivalent of glass beads were used to 
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lyse the cells. Bead beating was done for 6–8  min, intermittently, and the extracts were 
centrifuged, to clarify, and boiled at 95  °C for 5  min before loading the SDS–PAGE gel. 
Whole-cell protein extract and immunoblots 
Asynchronously grown mid-log (0.6–0.8 OD) phase cultures were lysed by SUMEB 
using glass beads, as mentioned above. For histones, 15% SDS–PAGE gels were run using 
Laemmli buffer. For Set2, RNA Polymerase II and Rad53 blots, 8% SDS–PAGE gels were run. 
Gels were transferred using a semi-dry Hoeffer apparatus at 45  mA per gel (constant current 
setting), 50  V for 1.5  h. For RNA Polymerase II, the Hoeffer setting was 55  mA per gel (constant 
current setting), 50  V for 1.5 h. Primary antibodies were incubated in 5% milk overnight and 
secondary antibodies were incubated in 5% milk for an hour. The immunoblots were developed 
using ECL-Prime from Amersham. Antibodies: H3K36me1 (ab9048; 1:1,000); H3K36me2 
(active motif 39255; 1:1,000 and 4  µl for ChIP), H3K36me3 (ab9050; 1:10,000 and 3  µl for 
ChIP), C-terminal H3 (EpiCypher 13-0001; 1:2,500 and 2  µl for ChIP), Set2 (raised in lab; 
1:5,000 or 1:10,000 and 5  µl for ChIP), Rad53 (obtained from Daniel Durocher, Canada; 1:2,000 
(for Fig. 4a; ref. 66) and Abcam 104232; 1:2,000 (for all other Rad53 blots), H2AS129ph 
(Active Motif 39271; 1:1,000 and 2  µl for ChIP), H2A (Active Motif 39235; 1:25,000 and 2  µl 
for ChIP), G6PDH (Sigma; 1:100,000), Ser2pCTD (1:100, gift from Dirk Eick, LMU, Munich, 
Germany), Rpb1 (Santa Cruz, yN-18, 1:1,000), anti-Myc (9E10, 1:2,500), 4H8 against RNA 
Polymerase II (Active Motif; 1:10,000 and 4  µl for ChIP). Rabbit (Amersham, Donkey anti-
Rabbit), goat and rat (both Jackson ImmunoResearch Laboratories) secondary antibodies was 
used at 1:10,000. RPA antibody (2  µl for ~1  mg of chromatin) from Valerie Borde (Insitut 
Pasteur, Paris, France) was used for ChIP in Fig. 9. 
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ChIP 
JKM179 and derivatives thereof were grown overnight in YPD and the saturated culture 
was used to start a fresh culture in YEP lactate, pH 5.5 (SC-Ura plus 2% Sucrose for Fig. 9F) at 
an OD600 of 0.1 and grown at 30°C till the OD600 reached 0.8–1.0. Galactose was added to a final 
concentration of 2% to induce the expression of HO endonuclease (at t=0  h). Samples were 
collected at required time-points and fixed with 1% (final concentration) formaldehyde. Cells 
were lysed using 300  mM FA lysis buffer (containing protease inhibitor cocktail). The lysed cells 
were sonicated (30% output, 6 pulses 6 times; 90% duty cycle) and clarified by centrifuging at 
full speed for 15  min. Immuno-precipitations were set up, overnight, with desired amount of 
proteins and antibodies (antibody amounts have been listed above). Protein G-sepharose beads 
(100  µl 1:10 diluted beads per 400  µl immunoprecipitation reaction) were added to the immuno-
precipitation reactions and the reactions were allowed to incubate for 1 hour. Subsequent washes 
were done in 1.4  ml of 300  mM FA Lysis buffer, 500  mM FA-lysis buffer and LiCl solution 
(250  mM LiCl, 10  mM Tris, 0.5% each of NP-40 and sodium deoxycholate and 1  mM EDTA). 
The immunoprecipitates were resuspended in TE (pH 8.0) and treated with RNase for 30  min. 
The immunoprecipitates were then washed with TE (pH 8.0) and elution buffer was used to elute 
the DNA (15  min incubation in elution buffer followed by centrifugation at 3,000 r.p.m. for 2 
minutes). The eluates were kept at 65°C overnight to carry out the de-crosslinking step and PCR 
purification kit (Qiagen) was used to extract the DNA. Details of PCR conditions, primer 
locations and analysis methodologies can be requested. 
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Immunoprecipitation 
Immunoprecipitation for Set2-FLAG was performed in accordance with the 
manufacturer’s protocol (SIGMA, catalogue no. A2220), using the 300  mM FA-lysis buffer used 
for ChIP experiments. 
MG-132 experiment 
Cells were grown in media containing proline as a nitrogen source overnight. The 
following morning, a fresh culture was started at OD 0.5 with 0.003% SDS and grown for 3  h 
before treatment with MG-132 (75  µM) for another 30  min. Subsequently, phleomycin 
(250  µg  ml−1) was added and samples were obtained at indicated times, and western blotting was 
performed as described above. 
Plasmid re-ligation assay 
About 3–5  µg of circular plasmids were digested by indicated restriction enzymes. 
Running the digested plasmids on gels and performing routine gel extraction confirmed their 
linearization. Subsequently, 100  ng of linearized or circularized plasmids were transformed into 
indicated strains (LiAc/PEG method), in parallel. The colonies were counted on Sc-Ura plates 
after 2–3 days. Three independent transformation reactions were carried out. 
Statistical analysis 
For arriving at the P values in all the relevant experiments (ChIP assays and the plasmid 
re-ligation assay), we carried out unpaired Student’s t-test in Microsoft Excel. The explanations 
for the error bars are mentioned in the corresponding figure legends with relevant n values. P 
<0.05 was considered statistically significant. 
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Table 3. Chapter two summary 
An RNA Polymerase II-coupled function for histone H3K36 methylation in 
checkpoint activation and DSB repair 
• Set2 regulates DSB signaling activation and DSB repair. 
• Set2-dependent H3K36me is dynamic after DSB and is regulated, at least in part 
through proteolytic destruction of Set2. 
• RNA Polymerase II is also degraded after DSB. 
• Set2’s function after DSB repair is dependent upon transcription and loss of Set2 
function from cells predispose them to perform homologous recombination. 
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CHAPTER 3: RATIONAL DESIGN OF H2A.Z MUTANTS UNCOVER DIFFERENTIAL 
CHAPERONE INTERACTIONS AND FUNCTION 
 
3.1 Overview 
H2A.Z (Htz1) is a histone variant that replaces canonical histone H2A in nucleosomes. It is 
involved in transcriptional regulation, DNA damage response, and heterochromatin silencing. 
H2A.Z deposition and eviction in chromatin is under the control of a number of ATP-dependent 
remodelers and histone chaperones. However, the underlying mechanisms for how these histone 
chaperones cooperate to deposit and evict H2A.Z in chromatin is lacking.  Here, we uncover a 
role for the Chz1 chaperone, along with Nap1, in evicting H2A.Z from chromatin.  Using 
molecular simulations, we refine a previously generated Chz1-H2A.Z-H2B structure to identify a 
series of H2A.Z residues that constitute part of a chaperone-specific binding surface. Mutation of 
these residues revealed differential requirements for Chz1 and Nap1 interaction.  We also found 
that several of these H2A.Z mutants resulted in modest to severe growth defects that could be 
restored upon deletion of the H2A.Z deposition machinery. Furthermore, we show that these 
mutations show aggravated phenotypes when the functionally redundant chaperone is deleted. 
Based on our findings we propose a mechanism of H2A.Z maintenance in chromatin through a 
functional interplay of the SWR1C complex that deposits H2A.Z and the Nap1/Chz1 chaperones 
that, at least partly, function to evict H2A.Z from chromatin.
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3.2 Introduction 
Eukaryotic chromatin is regulated by multiple mechanisms that include, but are not limited 
to, post-translational histone modifications, ATP-dependent chromatin remodeling, and 
replacement of canonical histones with variants 164. While the canonical histone proteins are 
mainly deposited in the S-phase of the cell cycle, histone variants are synthesized independent of 
replication and their deposition and eviction at specific genomic loci are associated with distinct 
chromatin states 164,165. Variants of histone H2A are the most common and are found in most 
organisms from yeast to humans. H2A.Z (Htz1 in yeast) is a histone H2A variant that is highly 
conserved across species 165-167. H2A.Z has been shown to be crucial for a variety of DNA 
processes involving regulation of chromatin structure during transcription 168-170, maintenance of 
heterochromatin 46 and DNA damage response 171,172.  
The function of H2A.Z is, in part, modulated by regulated deposition and eviction from 
chromatin 167,171. The major factor for regulated deposition of H2A.Z in chromatin is the SWR1 
complex (SWR1C) 173. SWR1C is an ATP-dependent chromatin-remodeling complex that 
recognizes the acidic surface on the H2A.Z-H2B dimer 174 to deposit it into chromatin. 
Additionally, histone chaperones Nap1 and Chz1 have been implicated in appropriate deposition 
of H2A.Z into chromatin 167. Nap1 is thought to import H2A.Z into the nucleus and deliver it to 
Swr1-deposition machinery 175. A novel H2A.Z-specific chaperone, Chz1, has also been shown 
to deliver H2A.Z to Swr1 depositing machinery 99. However, removal of Chz1 and/or Nap1 does 
not severely impact H2A.Z function or deposition of H2A.Z into specific chromatin loci 99. To 
date, no clear mechanistic understanding exists regarding the differential functions of Nap1 and 
Chz1 in depositing H2A.Z to chromatin. In this study, we have attempted to understand the 
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differential interactions between H2A.Z and its cognate chaperones – Nap1 and Chz1. Using 
structural modeling and discrete molecular dynamic (DMD) simulations, we have discovered 
specific residues on H2A.Z that are critical for interactions with either Chz1 or Nap1. Mutations 
in these residues lead to severe biological consequences, in terms of survival, with or without 
stressors (genotoxic or transcriptional). Using chromatin fractionation and genetic interactions 
between mutant H2A.Z residues and histone chaperones; we provide evidence that a major 
function of Nap1 and Chz1 is removal of H2A.Z from chromatin. 
 
3.3 Results 
3.3.1 Chz1 and Nap1 function in H2A.Z eviction 
Given the importance of H2A.Z incorporation at specific locations across the genome, we 
sought to understand the role of H2A.Z binding proteins Chz1, Nap1, Swc2 and  Swr1 (the 
remodeler involved in H2A.Z deposition) in modulating H2A.Z levels in chromatin. We utilized 
strains in which the genes encoding these proteins were deleted, and then determined both the 
cellular and chromatin-bound levels of H2A.Z in these strains. Deletion of nap1Δ, chz1Δ, swc2Δ 
and swr1Δ did not have any significant effect on overall H2A.Z protein levels in these strains 
(Fig. 12 & data not shown). However, chromatin-bound H2A.Z levels were significantly 
decreased in swc2Δ and swr1Δ, confirming Swc2 and Swr1 to be essential for H2A.Z deposition 
(data not shown). In contrast, we observed an increase in chromatin-bound H2A.Z levels in the 
absence of either Nap1, Chz1 or both indicating that their loss results in impaired eviction of 
H2A.Z from chromatin (Figs. 12A and B). To further understand the balance of H2A.Z 
deposition and eviction, we analyzed structural interactions of H2A.Z with Chz1 using the 
already available structural information for the Chz1-H2A.Z-H2B (CZB) complex 176. We 
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structurally defined important residues in H2A.Z that might be important in binding chaperones 
and H2A.Z depositing proteins. 
3.3.2 Constraint-driven CZB structural ensemble generated by DMD simulations 
The NMR and biochemical data suggest Chz1 to be an intrinsically unstructured protein that 
does not adopt a compact globular fold or significant secondary structure even upon binding to 
H2A.Z-H2B dimer 176. Hence, to better understand the molecular recognition of H2A.Z-H2B by 
Chz1, we performed replica-exchange DMD simulations to sample multiple conformations of the 
CZB complex 176. To ensure that the set of conformations (ensemble) of CZB we used for 
structural analysis reflected native conformations, we used a set of filters to select a subset of 
structures from all the snapshots obtained from the DMD simulations. Using filters that included 
potential energy, electrostatics and violations of published Nuclear Overhauser Effect (NOE) 
A
WT htz
1¨
na
p1
¨
na
p1
¨c
hz
1¨
ch
z1
¨
WT htz
1¨
na
p1
¨
na
p1
¨c
hz
1¨
ch
z1
¨
WT htz
1¨
na
p1
¨
na
p1
¨c
hz
1¨
ch
z1
¨
G6PDH
Htz1 (dark)
H4
Htz1 (light)
Total Soluble Chromatin
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
WT
htz
1
na
p1 chz
1
na
p1
chz
1
(Chromatin/Total) Htz1
(Chromatin/Total) H4
B
 
 
 
 
 
 
 
 
 
 
 
Figure 12:  nap1Δ and chz1Δ result in increased Htz1 levels in the chromatin. (A) 
Logarithmically grown cells were used to prepare the chromatin and the soluble fractions 
from the indicated strains. G6PDH was used as a control for the soluble fraction while H4 
was used as a control for the chromatin fraction. (B) The normalized data (amount of 
histones in chromatin/ amount of histones in soluble fractions in chromatin) from figure 
12A is shown in figure 12B. The level of H4 acts as a control for the relative levels of 
histones.  
 
a b 
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spectra of the CZB complex 176 we arrived at an ensemble of structures for the CZB complex 
(the DMD ensemble). In our DMD ensemble, the average violation of interface NOE constraints 
is 0.04 Å, lower than the average violation of interface NOE constraints in the published NMR 
ensemble (0.07 Å), thus indicating that the DMD ensemble of the CZB complex has excellent 
agreement with experimental distance restraints. 
 
3.3.3 Diverse interactions drive specific recognition of H2A.Z-H2B by Chz1  
 
Chz1 is unique compared to other histone chaperones of known structure; most of the 
histone recognition domain of Chz1 displays no secondary structure compared to globular, well-
folded histone-recognition domains of histone chaperones whose structures are known (such as 
Asf1 177 178, Nap1 179, Rtt106 180 and DAXX 181, 182). However, the extended coil structure of 
Chz1 enables an extensive and specific interface with H2A.Z-H2B. The histone recognition 
motif forms a lasso-like structure, covering two thirds of the circumference of H2A.Z-H2B (Fig. 
13A) and the chaperone-histone interface buries 2462.2 ± 151.5 Å2 solvent accessible surface 
area on average. To determine the binding interface of Chz1, we calculated average number of 
heavy-atom contacts formed by each residue of H2A.Z-H2B with residues of Chz1 in the 
ensemble. When we represent this binding interface as a heat map on the H2A.Z-H2B surface 
(Fig. 13B), we observe specific regions on the surface of H2A.Z-H2B that form interactions with 
Chz1. The highly negatively charged “acidic patch” of H2A.Z-H2B is specifically bound by a 
series of three arginine residues in Chz1 (R105, R106, R108, Fig. 13C). The DNA-binding 
surface of H2A.Z-H2B, which is highly positively charged, is bound by a negatively charged, 
highly complementary surface of Chz1 (Fig. 13D). 
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Figure 13: (A)  The six centroid structures from the refined DMD ensemble of H2A.Z-H2B-
Chz1 complex are structurally aligned and displayed using cartoon representation. The 
centroid structures are overlaid over the yeast nucleosome structure in gray, highlighting the 
surface on H2A.Z-H2B that is bound by both Chz1 and DNA. (B) The H2A.Z-H2B dimer is 
displayed using surface representation with the residues colored according to the average 
number of interface contacts they form with Chz1, which is displayed with the cartoon 
representation. The structures are overlaid over the yeast nucleosome structure in gray. The 
dashed-box indicates the region of H2A.Z-H2B surface that forms the acidic patch. The 
asterisk indicates the DNA-binding surface of H2A.Z-H2B. (C) The acidic patch from the 
H2A.Z-H2B dimer is shown using surface representation forming interactions from three 
arginine residues from Chz1. From the coloring according to interface contacts, we observe 
the residues forming acidic patch to interact with Chz1. From the electrostatic surface, we 
observe the high charge complementarity between acidic patch residues and Chz1 residues. 
(D)The DNA binding surface of H2A.Z-H2B is shown colored according to interface 
contacts. We observe several aspartate and glutamate residues from Chz1 to form specific 
interactions with this surface. The electrostatic surface shows the DNA binding surface to be 
highly positively charged. The nucleosome structure in gray is overlaid to highlight the path 
of DNA on this surface. 
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3.3.4 Interrogating the H2A.Z-H2B binding surface of Chz1 
To understand the cellular role of residues in H2A.Z surface that are specifically recognized 
by Chz1 (and possibly Nap1 that also interacts with this histone variant), we performed a 
computational screen (see materials and methods) of the effect of point mutations on H2A.Z that 
lie in the H2A.Z-Chz1 binding surface. From this analysis, we selected three mutations in H2A.Z 
that were predicted to decrease its affinity towards Chz1 (data not shown). These mutations 
were present in three different regions of the Chz1-H2A.Z interface. R39 is present on the DNA 
binding interface of H2A.Z and the mutation R39D is predicted to destabilize Chz1 binding. As a 
control, we also selected R48D, in the DNA binding interface of H2A.Z, which is chemically 
similar mutation to R39D but which is predicted to have no major effect on Chz1 binding. Y65 is 
part of the acidic patch and forms specific interactions with Chz1, with Y65K mutation predicted 
to severely impair Chz1 binding. As a control, we selected D98K in the acidic patch, which is 
predicted to have modest effect on Chz1 binding. L93, part of the helix α3, forms hydrophobic 
interactions with Chz1 and the L93T mutation is predicted to severely destabilize H2A.Z-Chz1 
interactions. S53 is part of loop1 and N76 is part of the long helix α2 and N76M and S53L are 
control mutations that are predicted to result in no significant change in H2A.Z-Chz1 
interactions. 
 
3.3.5 H2A.Z-Chz1 destabilizing mutants result in impairment of H2A.Z levels in chromatin  
With our predicted set of mutations that result in either destabilization or no effect on Chz1-
H2A.Z binding (Table 5), we next determined if these mutants would affect H2A.Z function 
and/or incorporation into chromatin. Point mutations were generated in a wild-type (WT) H2A.Z 
expression plasmid and then transformed in H2A.Z deleted cells. We first examined the 
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expression of these h2a.z mutants, and found that all of them expressed to a similar extent at the 
mRNA level (Fig. 14B).  In contrast, immunoblot analysis of whole cell extracts (Fig. 14A, 
upper panels) and isolated chromatin fractions (Fig. 14A, lower panels) revealed that the total 
and chromatin-bound levels of several H2A.Z mutants were significantly different compared to 
WT. The most dramatic decrease in H2A.Z protein levels was observed for the Y65K and D98K 
mutants, followed by the R39D mutant (Fig. 14A). It is noteworthy that while H2A.Z protein 
levels are significantly diminished globally and in chromatin, we are still able to detect trace 
amounts in chromatin (data not shown).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14:  Protein (A) and RNA (B) levels of Htz1 mutants and their ability to get 
incorporated into the chromatin. (A) Whole cell extract (Input) and chromatin levels of 
designated mutants. As seen from the immunoblot, some Htz1 mutants are expressed at low 
levels in the whole cell extracts (e.g. Y65K and R39D) while others are differentially 
incorporated in the chromatin (N76M). (B) The RNA levels of these mutants are equivalent in 
cells, thereby ruling out a problem with transcription of the constructs. Figure courtesy, 
Michael Parra (Heritage University, Washington State). 
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3.3.6 H2A.Z mutations disrupt specific chaperone interactions 
The altered cellular and chromatin-bound levels of our H2A.Z mutants led us to 
hypothesize that the decreases observed in H2A.Z might be due to altered binding of these 
mutants to one or more histone chaperones. To test this idea, we utilized TAP-tagged Nap1 and 
Chz1 strains in which H2A.Z was deleted and transformed with our H2A.Z mutants.  We then 
probed the extent to which our H2A.Z mutants could co-immunoprecipitate (coIP) with either 
Nap1 or Chz1. The extremely reduced levels of the Y65K and D98K mutants precluded their 
assessment in these assays (Fig. 14A).  In examination of Nap1-H2A.Z interactions, we found 
that the L93T mutant could immunoprecipitate with Nap1 at levels comparable to WT H2A.Z 
(Figure 2B).  Significantly, however, Nap1-H2A.Z interaction was abrogated by mutations of 
R48D, R39D and S53L (Fig. 15). In examination of Chz1-H2A.Z interactions, the extent of 
immunoprecipitation of R39D, R48D, S53L and N76M H2A.Z mutants with Chz1 were not 
significantly different from H2A.Z WT (data not shown). However, significantly lower 
interaction was observed between the L93T mutant and Chz1, which is consistent with our 
computational predictions that L93T would have the most severe effect on Chz1 binding (Table 
5). Thus, with rationally designed mutants of H2A.Z, we have uncovered two distinct classes of 
residues in H2A.Z that are critical for its interaction with different chaperones; R39D, R48D and 
S53L, part of the DNA binding interface of H2A.Z that is important for Nap1 interaction, while 
L93T on the α3 helix is essential for Chz1 interaction.  We also note that the striking decreases 
found in H2A.Z protein levels observed in the Y65K, D98K and R39D mutants in Fig. 14A are 
unlikely due to simple destabilization of Chz1 and/or Nap1 binding, as mutants that uncouple 
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these interactions do not result in lower H2A.Z levels. These observations suggest that the lower 
protein levels are due to another molecular mechanism rather than destabilization of H2A.Z- 
chaperone interactions.  
 
3.3.7 Mutations predicted to affect H2A.Z-chaperone interactions disrupt H2A.Z function 
Given the altered cellular and chromatin levels of our h2a.z mutants, along with the impaired 
H2A.Z-chaperone interactions we detected, we next asked if our h2a.z mutants would have any 
significant biological consequences in cells.  Strikingly, the Y65K and D98K h2a.z mutants 
revealed severe growth defects, and in the case of the D98K mutant, sensitivity to all of the 
genotoxic stress agents tested (Fig. 14A) similar to previous studies 174. To our knowledge, our 
finding that the Y65K mutant confers severe growth defects even in the absence of genotoxic 
stressors is the first example of any mutations in H2A.Z resulting in significant defects in cell 
 
Figure 15. Unique mutations disrupt Nap1-Htz1 interactions. Shown here is a co-
immunoprecipitation experiment between designated constructs of Htz1 and Nap1. Top two 
panels represent the input levels of the constructs and TAP-tagged Nap1, while the bottom 
two panel show pull-down efficiency between Nap1 and designated mutants of Htz1. As 
seen from the pull-down, and as predicted, R48D, R39D and S53L result in diminished 
interaction with Htz1. Figure courtesy, Michael Parra (Heritage University, Washington 
State). 
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viability. Of the mutations that we found to specifically affect either H2A.Z-Chz1 interaction 
(L93T) or H2A.Z-Nap1 interaction (R48D, R39D, and S53L), only the R39D mutation revealed 
a significant phenotype (i.e., sensitivity to caffeine and HU, similar to an h2a.z deletion (Fig. 
16A).  The R39D sensitivity is likely explained through the fact that the chromatin levels of this 
mutant are significantly down (Fig. 14A), rather than a specific disruption of chaperone 
interaction, as the R48D and S53L mutants that also disrupt Nap1-H2A.Z interaction show no 
phenotypes. The lack of observable phenotypes in the absence of preventing either Chz1- or 
Nap1-H2A.Z interaction is not surprising, as there is functional redundancy between these two 
chaperones 99.  To test this, we combined our point mutations with deletion of either NAP1 or 
CHZ1 and observed if we saw any growth defects after cellular stress. In line with our 
expectation, we observed that for mutations that disrupted Nap1-H2A.Z interaction (R48D), 
deletion of CHZ1 resulted in increased sensitivity to caffeine- a pleiotropic inducer of cellular 
stress (Fig. 16B, upper panel). Furthermore, when we deleted NAP1 in mutants with disrupted 
Chz1-H2A.Z interaction (L93T), we increased the caffeine sensitivity of such cells (Fig. 16B, 
lower panel).   In sum, we provide biochemical and biological evidence to suggest that Nap1 
and Chz1 have non-overlapping binding surfaces on the H2A.Z-H2B nucleosomes and due to 
this, they can partially make support each other’s function in dynamic incorporation/eviction of 
H2A.Z.  
3.3.8 Characterization of a novel and toxic H2A.Z form that is dependent on chromatin 
deposition  
 The severe growth defects and extremely low levels of H2A.Z observed with the Y65K and 
D98K mutants led us to next address what might be the molecular basis behind this phenotype.  
We first asked whether these mutant forms of H2A.Z were toxic due to the fact they were being 
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incorporated into chromatin, albeit at extremely low levels (Fig. 14).  If this were the case, we 
would predict that loss the H2A.Z deposition machinery would suppress the slow growth 
phenotype.  As shown in Fig. 15A, we found as expected that the Y65K h2a.z mutant was 
extremely sick under normal growth conditions.  Surprisingly, deletion of SWR1 in this context 
completely reversed the slow growth phenotype of the Y65K mutant (Fig. 17A), indicating that 
the Y65K growth defect is most likely caused by a defect of H2A.Z once deposited into 
chromatin. In contrast, deletion of NAP1 did not reverse the slow growth defect of the Y65K 
mutant – a result consistent with our findings and others 99 revealing that Nap1 is required for 
H2A.Z eviction, and thus, is not preventing this variant from being deposited into chromatin.  In 
addition to our growth assays under normal conditions, we also observed that the strong 6-AU 
(but not HU) sensitivity of the Y65K mutant was also reversed by deletion of SWR1 and not 
NAP1 (Fig. 17A). Taken together, these data imply that the toxicity of Y65K mutant is likely due 
to its deposition within chromatin, and that this mutant form is rapidly degraded.  
The finding that the toxic phenotype of the Y65K h2a.z mutant could be reversed by deletion 
of SWR1 led us to ask if swr1Δ would have any effect on the cellular levels of the Y65K H2A.Z 
protein.  We examined the levels of WT or Y65K mutant H2A.Z levels in h2a.zΔ, h2a.zΔ/swr1Δ 
or h2a.zΔ/nap1Δ deleted cells. As expected, little to no Y65K H2A.Z levels were detected in the 
h2a.zΔ cells (Fig. 17B).  In contrast, we found that deletion of SWR1, but not NAP1, restored 
Y65K H2A.Z levels to near WT levels (Fig. 17B). These data indicate that the incorporation of 
the Y65K mutant H2A.Z form is the basis for both the toxic phenotype as well as the rapid 
turnover. 
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Figure 16. Biological consequences of the point mutants of Htz1. (A) Five-fold serial 
dilutions of indicated strains were spotted on either control (Sc-Ura) or drug-containing 
plates. The Y65K and D98K mutants of H2A.Z are slow growing. Mutants show varying 
degree of sensitivities to HU, Rapamycin, Caffeine and 6-AU. (B) Mutants of Htz1 
combined with chaperone deletion increases the sensitivity to stress such as Caffeine. 
Shown in the supper panel is the combination of Htz1 mutant R48D, which disrupts Nap1-
Htz1 interaction, and CHZ1 deletion while the lower panel is the combination of Htz1 
(L93T) mutant and NAP1 deletion. The figure elucidates that loss of a chaperone, when 
combined with mutations of Htz1 that disrupt Htz1-chaperone interactions result in grave 
consequences for the cell.  
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Figure 17. Chaperone deletions differentially effects H2A.Z mutations. (A) Deletion of 
SWR1 can restore the slow-growth phenotype of the Y65K mutant while nap1Δ cannot. (B) 
Immunoblots showing the expression levels of H2A.Z off of plasmids in various strains. Y65K 
has lower H2A.Z protein levels, which can be at least partially rescued by swr1Δ and swc2Δ.  
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 Discussion 
An essential mechanism that underlies epigenetic regulation is the incorporation of 
histone variants, including H2A.Z, at specific genomic loci. Yet, how variant proteins are 
deposited and removed, in addition to what affect they have on chromatin structure and function 
remains a fundamental question in chromatin biology.  Here, we provide new evidence that the 
Chz1 and Nap1 chaperones function, parallelly, to evict H2A.Z from chromatin (Fig. 12 and data 
not shown).  These findings suggest a mechanism that precisely maintains H2A.Z levels in 
chromatin: deposition by SWR1C and eviction by Chz1/Nap1.  How these two chaperones 
coordinate their activities, both temporarily and spatially, remain to be determined in future 
studies. 
To uncover structural underpinning of chaperone-H2A.Z interaction, we generated a 
refined model of H2A.Z-bound to Chz1. Structure and conformational dynamics of the Chz1-
H2A.Z-H2B (CZB) complex revealed a unique mode of histone recognition by Chz1 compared 
to other chaperones of known structure. Importantly, the binding interface of Chz1 encompasses 
the DNA-binding surface of H2A.Z and the acidic patch, in addition to H2A.Z-H2B surface 
distal to these regions. Swc2 (VSP72) binds to the acidic patch of H2A.Z 99,174 and mutations in 
this region lead to diminished but not total abrogation of H2A.Z incorporation into chromatin 174, 
implying that multiple interactions of H2A.Z (including Swc2 and Chz1) would be affected by 
mutations in the acidic patch. Although two acid patch mutations were generated to interrogate 
Chz1-H2A.Z and Swc2-H2A.Z interaction in this study (Figures 13 and 14), we found 
unexpectedly that they were slow growing and had extremely low levels of H2A.Z – thus 
precluding further binding studies (see below and Figure 16). 
  
 79 
Interestingly, all the mutants designed in the DNA-binding interface (Figure 18) showed 
abrogated interaction with Nap1 but not Chz1 (Figure 14 and data not shown). These data allow 
us to define multiple surfaces that are employed to engage specific chaperones for H2A.Z 
function.  Such distinct binding surfaces for Chz1 and Nap1 may explain the synthetic sick 
genetic interaction between the two chaperones 175.  
 Two of the H2A.Z mutations identified in our simulations (Y65K and D98K) resulted in 
severely reduced H2A.Z protein levels and defective growth that was worse than h2a.z∆. To test 
our hypothesis that the severe effects of these mutations are due to specific incorporation of 
mutant H2A.Z into chromatin, we performed chaperone deletions in the background of Y65K. 
We were able to rescue the slow growth phenotype of Y65K by deleting either SWR1 or SWC2 
but not NAP1, suggesting that it is not the low level of H2A.Z per se in cells, which is harmful 
but rather the deposition of a form of H2A.Z that can’t be evicted (i.e. Y65K). In line with this 
idea, we observe an increase in H2A.Z protein levels in the Y65K mutant in the background of 
swr1∆ and swc2∆, where the mutant H2A.Z can’t be deposited into the chromatin (Figure 17). 
Although an understanding of how these two mutants cause severe growth defects is not 
understood, it may be that these mutants alter nucleosome structure and/or dynamics at gene 
promoters to inappropriately affect gene transcription.  It is interesting to speculate that the 
acidic patch might have multiple functions in chromatin by making functionally important intra- 
and/or inter-nucleosomal interactions that then are disrupted by Chz1 during the removal of 
H2A.Z, but used by Swc2 during its deposition.  
Here we present a model of H2A.Z regulation by showing that Chz1 and Nap1 function 
to evict H2A.Z from chromatin.  Together with the fact that Swr1 functions to deposit H2A.Z 
into chromatin, the collective data suggest that H2A.Z is tightly regulated by the actions of 
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chaperones that function to deposit and evict in order to maintain precise levels of H2A.Z in 
cells.  It is the equilibrium of this deposition vs. removal that ultimately dictates the H2A.Z 
levels in chromatin, and hence genome function.  Outside of H2A.Z, a similar mode of 
regulation has been made for the centromeric histone H3 variant, Cse4 98. Deletion of Snf2, a 
chaperone for the centromere specific histone Cse4, leads to marked mis-localization of this 
histone variant leading to aneuploidy. In light of similar results with respect to H2A.Z in recent 
studies 183, we surmise that mutant H2A.Z incorporation leads to mislocalization of H2A.Z in the 
genome that can lead to genome instability and hence defective growth.  
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Figure 18. Hypothetical model for the basis of “separation-of-function” between different 
H2A.Z-specific chaperones. Chz1 forms a lasso-like structure around the dimer, forming 
interactions at multiple regions. Nap1 mainly interacts through the DNA-binding region of 
H2A.Z-H2B and Swc2 interacts with the acidic patch. This model explains our and others’ 
observations that Nap1 and Chz1 have non-overlapping functions in buffering the H2A.Z levels in 
the chromatin while the Swr1 complex regulates its deposition. 
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3.5 Materials and methods 
CZB constructs used in structural studies. We used the NMR structure of CZB (PDB ID: 
2JSS) as a starting structure for our simulations. This construct consists of H2A.Z (residues 22-
118, UniProt ID: Q12692), H2B (residues 36-130, UniProt ID: P02294) and Chz1 (63-124). The 
NMR sample was constructed by connecting the C-terminus of H2B and N-terminus of H2A.Z 
to form a single peptide chain. In the construct used in our simulations, we treated H2A.Z and 
H2B as separate chains.  
CZB DMD simulations. We employed replica exchange, parallelized discrete molecular 
dynamics to sample ensemble of conformations of the CZB complex. The DMD simulation 
methodology is described in detail elsewhere 184-186. Briefly, we use Medusa force field 187 that is 
based on CHARMM19 non-bonded potentials 188, EEF1 implicit solvation parameters 189, 
geometry-based hydrogen bond potential and long-range electrostatic potential 190 to model 
various macromolecular interactions. The time unit of the all-atom DMD simulations is ~50 
femtosecond 188 and the temperature is maintained using Anderson’s thermostat 191. We 
performed ten sets of DMD simulations for ~1 x 106 time units with a total of 16 replicas, 
resulting in total sampling of ~160 x 106 time units, or ~8 µs. The 16 replicas were set at 
following temperatures: 0.480, 0.495, 0.512, 0.528, 0.546, 0.563, 0.581, 0.600, 0.619, 0.638, 
0.658, 0.679, 0.700, 0.722, 0.744 and 0.767 ϵ (reduced units186; roughly corresponds to 240-
383K). To increase sampling of Chz1, so as to optimize the Chz1-histone interface, while biasing 
the simulations towards known experimental data, we utilized two sets of constraints: (i) the 
backbone atoms of H2A.Z (Residues: 26-113) and H2B (40-129) were harmonically constrained 
to their starting coordinates with a spring constant of 0.4 kcal.mol-1.atom-1 50 the distance 
between a subset of atoms of Chz1 and the histones (determined using Nuclear Overhauser 
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Effect (NOE) – NMR spectroscopy), were restrained with a two-well potential (Supplementary 
Figure 3). The list of NOE restraints were utilized from earlier study with minor modifications 
176: (i) Since our force field does not consider aliphatic hydrogens, the constraints containing 
aliphatic hydrogens were modified to contain the carbon atom to which the hydrogens were 
bonded, and the constraint length was increased by 1 Å to reflect the additional bond-length; 50 
all restraints were increased by 1 Å to account for the standard deviation of the NOE signal. 
Simulations analysis – identifying a refined CZB ensemble. We calculated several 
parameters of the simulation snapshots to identify a subset of snapshots (the refined ensemble) 
that features an optimized protein-protein interface and also agrees well with experimental 
distance restraints. We used our published electrostatic potential 185, Medusa potential 187 and the 
mean NMR violations as criteria to identify the refined ensemble. If the distance between two 
atoms is higher than the experimental distance, the difference between the observed distance and 
the experimental distance gives the violation value for that distance restraint. The average of 
such values over all distance restraints gives the mean NMR violation. After filtering out high 
energy structures and structures with high NMR violations, we identified a refined ensemble of 
1454 structures. We determined the mean NMR violation of this refined ensemble as follows. 
Since the NOE signal is proportional to the ensemble-averaged 1/r6 between two atoms, we 
determined the average 1/r6 from our filtered ensemble and then calculated r from that average. 
This distance r for each distance restraint was used to calculate the mean NMR violation of the 
ensemble. We observe the mean NMR violation of this ensemble to be lower than observed for 
the published NMR ensemble, indicating excellent agreement with experimental structural data 
for the CZB complex. 
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Interface analysis. We define a contact as a pair of atoms (one from H2A.Z-H2B and the 
other from Chz1) that are not hydrogen and are within a distance of 6 Å of each other. For the 
refined ensemble from DMD, we calculated the average number of contacts formed by each 
residue of H2A.Z-H2B with Chz1. We colored each residue in the H2A.Z-H2B interface with 
Chz1 (on structural figures) based on the average number of contacts formed by the residue. 
Estimation of change in binding affinity upon mutation. We calculated the change in 
binding energy of H2A.Z-H2B to Chz1 upon mutation using Medusa 192-194. We performed 17 
possible point mutations (all residues except proline, cysteine and the native amino acid) at all 
residues of H2A.Z that were part of the interface with Chz1 (Figure 1C) to determine a list of 
mutations that destabilize the CZB complex. Medusa calculations involve a Monte Carlo based 
simulated annealing procedure that uses rotamer libraries of amino acids for fast minimization of 
its energy function while leaving the backbone fixed. Medusa uses a combination physics-based 
terms (van der Waals, hydrogen bond, solvation) and knowledge-based terms (backbone and side 
chain torsions). We averaged the free energy obtained from at least 500 Medusa calculations for 
each of the six centroid structures (from the refined ensemble) to obtain ∆∆G for each mutation. 
We define ∆∆G as: 
DDG = (DGComplex-Mut - DGH2A.Z-H2B-Mut) - (DGComplex-WT - DGH2A.Z-H2B-WT), 
where DGComplex-Mut is the stability of the mutant H2A.Z-H2B-Chz1 complex, DGH2A.Z-H2B-Mut is 
the stability of the mutant H2A.Z-H2B dimer, DGComplex-WT is the stability of the wild type 
H2A.Z-H2B-Chz1 complex and DGH2A.Z-H2B-WT is the stability of the wild type H2A.Z-H2B 
dimer. Thus, a destabilizing mutation would result in a positive ∆∆G. 
Yeast strains and plasmids. The chromosomal copy of the histone H2A.Z (HTZ1) gene was 
deleted in the following yeast strains: 1) a strain bearing TAP-tagged Chz1 (Open Biosystems), 
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2) a strain bearing TAP-tagged Nap1 (Open Biosystems), 3) a strain bearing nap1D (Open 
Biosystems), 4) a strain bearing swr1D (Open Biosystems), and 5) a strain bearing swc2D (Open 
Biosystems). H2A.Z was replaced with the NatMX gene deletion cassette in these strains using 
PCR mediated gene disruption 195. The resulting yeast strains were screened on media containing 
cloNAT (Werner Bioagents) at 100 mg/mL. Strains were confirmed by PCR amplification and 
Western blot analysis. Plasmids containing either a WT or mutant H2A.Z allele (see below) were 
transformed into the resulting deletion strains. Yeast strains used in this study are listed in Table 
7.        
Plasmid construction. The pRS416-based Htz1-2Flag vector (a gift from Dr. C. Wu) was 
used as a template to generate all subsequent plasmids bearing mutations to H2A.Z. All 
mutations were made by site directed mutagenesis (QuikChange kit, Stratagene) and confirmed 
by sequencing.  
Whole cell extract, Chromatin fractionation and Immunoblotting. For analysis of total 
protein levels, whole cell extracts were made using established protocols 196. Chromatin was 
isolated from strains using established protocols 137. Electrophoresis and immunoblot analysis 
were performed as described elsewhere 197.  
Co-immunoprecipitation. H2A.Z was deleted in the TAP-CHZ1 and TAP-NAP1 (from 
Open Biosystems) and co-immunoprecipitation was performed as before 172.  
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Table 4: Chapter 3 Summary 
Rational Design of H2A.Z Mutants Uncover Differential Chaperone Interactions and 
Function 
• Nap1 and Chz1 are involved in evicting Htz1 from chromatin.  
• Nap1 and Chz1 have non-overlapping surfaces of interaction on H2A.Z-H2B 
nucleosomes 
• Rationally designed mutations in Htz1 disrupt the interaction between Nap1/Chz1 
and H2A.Z-H2B and they have biological consequences on cellular response to 
stress.  
• Inappropriately deposited mutants of H2A.Z result in massive defects in cellular 
growth and the phenotype can be suppressed by deleting the H2A.Z deposition 
machinery.  
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CHAPTER 4: CONCLUSIONS, UNANSWERED QUESTIONS AND DISEASE 
RELEVANCE 
4.1 Conclusion for Chapter 2 
Eukaryotic cells experience a plethora of DNA lesions; the most severe form being a 
DNA double-strand break (DSB), which can result in chromosomal rearrangements or cell death. 
DSBs can be caused by endogenous events (e.g., meiotic DSBs or replication through single-
stranded nicks) and exogenous agents (e.g., exposure to gamma-radiation). Cells respond to 
DSBs by activating the DNA damage response (DDR), which performs a number of functions 
including delaying the cell cycle to facilitate DNA repair. In mammalian cells, induction of 
DSBs activates the ATM and ATR  (Tel1 and Mec1 in budding yeast) kinase-signaling cascades, 
which results in phosphorylation of downstream substrates such as histone H2A.X (H2A in 
yeast) and 53BP1 (Rad9 in yeast). Two major pathways, non-homologous end joining (NHEJ) 
and homologous recombination (HR), repair the majority of DSBs, and pathway choice is 
contingent on whether DSB ends are resected or not. This is dependent on the balance between 
factors promoting NHEJ (Ku, 53BP1, RIF1) and resection (CtIP, MRN, EXO1, BLM and 
DNA2), which is in turn influenced by chromatin structure and the phase of the cell cycle in 
which DNA damage occurs.  
An emerging theme is the critical role that chromatin plays in multiple aspects of the 
cellular response to DSBs109109109. Lysine 36 methylation of histone H3 (H3K36me) is a post-
translational modification conserved from yeast to human cells. In yeast, Set2 is the sole 
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methyltransferase that catalyzes H3K36 mono-, di- and tri-methylation (H3K36me1, 
H3K36me2, and H3K36me3), whereas its human ortholog, SETD2, catalyzes only H3K36me3. 
Through an association with the hyper-phosphorylated, elongating form of RNA Polymerase II 
(RNAPII), Set2/SETD2 is recruited to the bodies of actively transcribed genes where it catalyzes 
H3K36 methylation. One major function for Set2-mediated H3K36me2/me3 in budding yeast is 
the recruitment and activation of a histone deacetylase complex (Rpd3S) as well as an ATP-
dependent chromatin-remodeling complex (Isw1b). These complexes function in the wake of 
elongating RNAPII to maintain chromatin integrity by creating a compact chromatin 
environment restrictive to intragenic or ‘cryptic’ transcription. In human cells, H3K36me2 
catalyzed by SETMAR/Metnase has been implicated in non-homologous end joining (NHEJ). 
H3K36me3 catalyzed by SETD2 also prevents cryptic transcription and regulates alternative 
splicing888888 and mismatch repair. Five new papers from the de’Almeida, Humphrey, Legube 
and Strahl labs 1,91,198-200 further expand the function of Set2/SETD2 and H3K36 methylation by 
demonstrating their involvement in DDR and DSB repair. Here, we draw evidence from these 
five recent publications to compare and contrast the emerging roles of yeast Set2 and human 
SETD2 in three main aspects of DSB repair: DDR, NHEJ/HR pathway choice and the link 
between transcription and DNA repair.   
Two of the aforementioned studies support roles for yeast Set2 and human SETD2 in 
DNA damage checkpoint activation. Using budding yeast as a model system, Jha and Strahl 
show that loss of H3K36me resulting from Set2 deletion (set2Δ) leads to reduced 
phosphorylation of histone H2A Ser129 and Rad53, signifying attenuated DNA damage 
checkpoint activation. Similarly, using human clear cell renal cell carcinoma (ccRCC) cell lines, 
Carvalho et al., show that activation of DDR is defective in SETD2-deficient or -depleted cells, 
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as measured by reduced ATM activation, γH2AX, delayed 53BP1 recruitment to DNA damage 
sites, p53 stabilization and downstream activation of p21, the major cyclin-dependent kinase 
inhibitor that is required for DNA damage dependent cell-cycle arrest. These findings are 
consistent with a reported role for Set2 in checkpoint activation in fission yeast, and indicate that 
Set2/SETD2 impacts a very early aspect of DNA damage sensing, an unexpected finding for a 
histone modification.  
In two yeast model systems, both Jha and Strahl (budding yeast) and Pai et al. (fission 
yeast) show that Set2 promotes NHEJ (Fig.19a) 1,198. Jha and Strahl show that deletion of SET2 
or mutation of H3K36 is sensitive to DSBs induced by phleomycin, radiation, or a Homothalic 
(HO)- endonuclease. In the case of fission yeast, Pai et al. show that Set2 promotes Ku 
recruitment and/or retention at a DSB. Using a mini-chromosome based DSB repair assay, they 
show that loss of Set2 substantially increases the frequency of gene conversion, suggesting that 
Set2 inhibits HR. Similarly, Jha and Strahl observed that when a linearized plasmid was 
transformed into set2Δ cells, re-ligation efficiency was significantly increased and was almost 
entirely dependent on Rad51 – an HR component. This suggests that loss of Set2 favors repair 
via HR. Consistent with these observations, studies in both fission and budding yeast indicate 
that loss of Set2 results in a relatively open chromatin structure, as measured by chromatin 
immunoprecipitation (ChIP) of acetylated histone H4, Htz1 (yeast homolog of the mammalian 
H2A variant, H2A.Z) and micrococcal nuclease (MNase) digestion. This, in turn, increases 
resection kinetics (as measured by loss of input DNA signal, increased recruitment of RPA by 
ChIP in G1-arrested cells and increased RPA recruitment by immunofluorescence), indicating 
that loss of Set2 promotes recruitment of the HR repair machinery.    
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These yeast studies also revealed that H3K36 modification influences repair pathway 
choice. Pai et al. demonstrate an antagonistic relationship between H3K36me3 and H3K36 
acetylation (H3K36ac) by showing that deletion of the H3K36 methyltransferase, Set2, increases 
the level of H3K36ac and reduces NHEJ. Conversely, deletion of the H3K36 acetyltransferase, 
Gcn5, increases the level of H3K36me3 and reduces HR. Collectively, these results suggest that 
Set2 and Gcn5 compete to modify H3K36, creating a ‘chromatin switch’ between NHEJ and HR. 
Furthermore, they show that H3K36me levels are high in G1 and H3K36ac levels are high in 
S/G2, and that the cell cycle distribution of these histone modifications conform to the preferred 
repair pathway in each cell cycle phase: NHEJ in G1 and HR in S/G2. 
In contrast to the above findings, human SETD2 is required for HR (Fig. 19b) 91,199,200. 
Using a well-established GFP reporter system in which repair of an I-SceI endonuclease-induced 
DSB by HR generates an intact GFP gene, Aymard et al., Carvalho et al., and Pfister et al. show 
that siRNA-mediated depletion of SETD2 resulted in reduced HR. Loss of SETD2 also reduced 
formation of RPA foci 91, RAD51 foci 91,199 and recruitment of RAD51 to DSBs, as measured by 
ChIP 91,200. Moreover, SETD2 depletion reduces DSB end-resection, as shown by an in vivo 
assay that measures single-stranded DNA generated by the resection machinery in the vicinity of 
a DSB 91. Together, the Aymard et al. and Pfister et al. studies support a model in which SETD2-
dependent H3K36me3 anchors Lens Epithelium-derived Growth Factor p75 (LEDGF) to 
chromatin through its PWWP domain. Following DSB induction, chromatin-bound LEDGF 
recruits the resection enzyme CtIP, which promotes resection and recruitment of 
RAD51. However, Carvalho et al. showed that RAD51 recruitment was reduced without defects 
in resection.  
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Figure 19. H3K36 methylation functions in DSB sensing and repair. (A) In the context of 
transcribing RNAPII, yeast Set2 catalyzes all forms of H3K36 methylation (mono-, di- and 
trimethylation). Set2 methylation contributes to transcription elongation by recruiting deacetylases 
and ATP-dependent remodeling complexes to maintain chromatin integrity. Five recent reports9–13 
identify a new role for Set2 in DSB repair. In budding and fission yeast, Set2 is recruited to sites of 
DSBs in an RNAPII-dependent manner. H3K36 methylation regulates DNA-integrity-checkpoint 
activation, chromatin architecture at DSBs and repair-pathway choice (preference for NHEJ). P 
denotes phosphorylation. (B) In human cells, preexisting H3K36me3 marks generated by SETD2 
during transcription are used to anchor LEDGF, which in turn recruits CtIP after DSB induction to 
promote DNA end resection and repair of the DSB via HR. The lightning bolt indicates a DNA-
damage event generating a DSB, and red nucleosomes indicate the +1 nucleosome at the 5′ end of 
genes, which typically contains the H2A variant H2A.Z (Htz1) and is marked by histone acetylation. 
CTD, C-terminal domain. 
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As opposed to what was observed in human cells, both yeast papers show that 
Set2/H3K36me negatively regulates DNA end resection. One reason for the apparent 
discrepancy could arise from the possibility that in the absence of SETD2, reduced damage-
induced γH2AX phosphorylation may lead to reduced 53BP1 recruitment, thereby permitting 
resection, a result alluded to in Carvalho et.al. However, resection in mammalian cells is 
compromised by the additional requirement for SETD2 to recruit CtIP, in a LEDGF-dependent 
manner. In yeast, loss of Set2 may similarly reduce Rad9 (53BP1) recruitment through reduced 
H2A phosphorylation or other checkpoint-dependent events, thus permitting resection. 
Nevertheless, LEDGF is not evolutionarily conserved in budding and fission yeast. Thus, in 
contrast to mammalian cells, Sae2 (CtIP) may be recruited to DSB sites independently of Set2, 
thereby promoting efficient resection and HR in yeast. In addition, Set2 in yeast catalyzes all 
three forms of H3K36 methylation (me1, me2 and me3), while human SETD2 catalyzes only 
H3K36me3. Therefore, the differences between yeast and human cells could also be a result of 
different methylation states having different, perhaps even opposing, functions after DSBs are 
formed. Indeed, human H3K36me2 promotes NHEJ while H3K36me3 promotes HR. Moreover, 
SETD2 is significantly larger than the yeast Set2 proteins, with an extended uncharacterized N-
terminus which may harbor unique functions in the repair process. 
The demonstrated role of Set2/SETD2 in DNA repair raises the question of whether 
H3K36me3 levels increase in response to DNA damage. In the two yeast systems, H3K36me3 
rapidly accumulates at the site of DSBs, but in human cells, no increase in SETD2 or H3K36me3 
was observed at DSB sites 91,199,200, suggesting that H3K36me3 levels are pre-set, presumably by 
prior transcription, and may be sufficient for downstream functions in DSB repair. Indeed, 
Aymard et al. show that, in human cells, HR preferentially repairs transcriptionally active 
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regions. A rare-cutting endonuclease (AsiSI) was used to generate around 150 DSBs across the 
genome, which were then sub-divided into RAD51- or XRCC4-enriched DSBs by chromatin 
immunoprecipitation-sequencing (ChIP-seq). RAD51 enrichment implied the use of HR while 
XRCC4 enrichment suggested that the DSB was being repaired by NHEJ. Surprisingly, RAD51-
enriched DSBs tended to occur in transcriptionally active regions and this preference was lost 
when transcription was abolished by addition of the transcriptional inhibitor DRB. Conversely, 
reactivating a repressed gene directed DSB repair towards HR.  These findings indicate that HR 
preferentially repairs DSBs in transcriptionally active regions of the genome. Given that 
H3K36me3 is correlated with transcription frequency and gene length in yeast, it will be 
interesting to investigate how DSBs are repaired in genes of varying lengths and transcription 
rates in human cells.  
Additional support for a transcription-coupled function for Set2/H3K36me was provided 
by Jha et.al 1. By using a truncated form of Set2 that inhibits its interaction with RNAPII, these 
authors demonstrated that Set2 association with RNAPII is critical for its DNA repair function. 
Furthermore, Jha and Strahl observed a substantial reduction in the protein levels of Set2 and 
RNAPII after DSB, which they found to be reduced in a proteasome-dependent manner. Why 
RNAPII and Set2 are degraded after DSB induction remains unclear, but the requirement to 
prevent transcription around a DSB to allow for DNA repair events might offer a plausible 
explanation. The interaction of Set2 with RNAPII is conserved in human cells as well, thereby 
raising the intriguing possibility that the role defined for H3K36 methylation in DSB signaling 
and repair in all organisms is intertwined with transcription elongation. Further studies will be 
needed to elucidate how transcription-dependent H3K36me regulates DSB repair. 
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 The identification of a role for H3K36me3 in HR in human cells contrasts with a previous report, 
which showed that SETMAR/Metnase-mediated H3K36me2 promotes DSB repair through 
NHEJ. The distinct repair pathways associated with H3K36 di-methylation (NHEJ) and tri-
methylation (HR) suggests the tantalizing prospect that, in mammalian cells as in yeast, H3K36 
modification contributes to DSB repair pathway choice, albeit via different histone marks. 
However, studies by Pfister et al. showed that depleting SETD2-dependent H3K36me3 results in 
reduced HR while NHEJ was unchanged. The authors inferred the pathways taken by the 
induced DSB by using an I-SceI inducible DSB in the HPRT gene and sequencing the repair 
products.  Surprisingly, depleting either SETD2 or RAD51 resulted in a significant increase in 
microdeletions, with break junctions being associated with regions of micro-homology (2-4bp) 
on either side of the break site.  These findings suggest that HR genes may suppress micro-
homology mediated end-joining (MMEJ), in which end-joining is dependent on short stretches of 
micro-homology. Microdeletions also frequently occur in various cancer cells and the 
observation that loss of SETD2 increases the incidence of micro-deletions has repercussions for 
tumorigenesis in cancers in which SETD2 is frequently mutated (e.g., clear cell renal carcinoma 
(ccRCC)). 
If H3K36me functions in DSB repair, one would expect that this histone mark would 
help to maintain genome integrity.  In agreement with this hypothesis, Kolodner and colleagues 
used bioinformatic analysis to show that the budding yeast SET2 gene shows genetic interaction 
with genes that suppress gross chromosomal rearrangement (such as MRE11, RAD9) – thereby 
reinforcing the idea that loss of Set2 might contribute to chromosomal abnormalities. 
Furthermore, and outside of DSB repair, Li et al. 90 showed that SETD2/H3K36me3 also 
contributes to DNA mismatch repair in an MSH6-dependent manner. The authors showed that 
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MSH6 is recruited to chromatin through an interaction of MSH6 (its PWWP domain) with 
H3K36me3, which aids in repairing nucleotide mismatches. Consistent with an important role 
for SETD2 in maintaining overall genome stability, SETD2 was identified as a tumor suppressor, 
and is frequently mutated in a number of cancer types. The identification of roles for 
SETD2/H3K36me3 in DDR, DSB repair, along with mismatch repair provide new mechanistic 
insights into how SETD2 may function as a tumor suppressor. 
4.2 Outstanding Questions 
 Some important outstanding issues relating to set2/SETD2 and genome stability raised by these 
studies include: (1) What is the mechanism by which SETD2 promotes DNA damage checkpoint 
activation? Although, two studies have shown that there is attenuation of DNA damage 
checkpoint activation in yeast and human cells, both these studies did not elaborate on the 
mechanism of this attenuation. Our study raises the possibility that this can be achieved in two 
non-exclusive ways: a) Since we show that there is more Htz1 containing nucleosomes around 
the DSB, there is not enough substrate for Tel1 in yeast cells to subsequently phosphorylate 
around a DSB. b) We have also shown that loss of SET2 results in an open chromatin 
environment surrounding the DSB- as evidenced by more Htz1 and more H4 acetylation. This 
open chromatin structure resulted in increased resection kinetics, as seen by faster loss in input 
DNA and increased RPA recruitment. As a result of faster resection, Tel1 may get removed from 
the chromatin, reducing the overall level of Tel1 around the DSB and thus reduced DNA damage 
checkpoint activation.  
Another interesting possibility can come from abrogated acetylation-dependent activation 
of ATM kinase. In human cell, ATM gets acetylated by Tip60 HAT, which is recruited to the 
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chromatin through its interaction with H3K9me3. The domain that recognizes H3K9me3 
(chromo-domain in a Tip60 subunit), also recognizes H3K36me and therefore loss of H3K36me 
from the chromatin may reduce the recruitment or stability of Tip60 on the chromatin.  
(2) Is there any correlation between transcription rate or gene length and the repair 
proficiency of DSBs induced in gene bodies? Transcription of genes involves major disruption of 
chromatin structure and generation of free DNA stretches. These free DNA stretches can be 
temporarily bound by nascently transcribed RNAs to form what is called R-loops. These R-loops 
are inherently recombinogenic, and can induce DSB. In line with this idea, R-loops tend to 
induce Serine 10 phosphorylation of histone H3 (H3S10ph), which tends to repress the 
chromatin. It would be intriguing to monitor the DSB frequency in various regions of the 
genome and correlate them with transcription frequencies enrichment of particular histone 
modifications and repair pathway choices for those DNA breaks. Using the Asi-inducible DSB 
system generated in the Legube lab, followed by RNA-seq of the transcriptome and chip-seq for 
XRCC1 and Rad51, we can perform these experiments.  
(3) What is the mechanistic basis and significance of RNAPII degradation after DSB 
induction? In out study, we clearly showed that just like what happens after UV exposure, 
RNAPII gets degraded after DSB. This degradation was clearly dependent upon the proteasome 
function. Besides the degradation of RNAPII, we showed that Set2 was also degraded after DSB, 
in a fashion that does not solely depends on the presence of checkpoint kinases. One interesting 
possibility is that other kinases such as stress- activated kinases (e.g. Hog1) or kinases activated 
due to nutritional stress (e.g. PKA/PKC) can phosphorylate and help in regulating Set2 levels 
after DSB. For RNAPII, the degradation can be triggered by the same Def1-Rsp5 system, which 
targets it for degradation after UV-damage. To get at these questions, we can use the MultiDsk 
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protein, which is an affinity tag consisting of multiple ubiquitin-binding domains from the Dsk1 
protein in yeast. We can pull immuno-affinity precipitate the ubiquitinated proteome with the 
multi-dsk tag  and then immunoblot for RNAPII. This experiment can be performed in wt and 
mutant strains (such as Def1delete, Rsp5 temperature sensitive and other candidate E3 ubiquitin 
ligases). (4) What is the contribution of SETD2/H3K36me3 loss-dependent MMEJ to 
chromosomal aberrations in tumorigenesis? While many mechanistic questions remain, it is clear 
that these findings define H3K36me as a critically important and evolutionarily conserved 
chromatin mark in maintaining genome stability. Our studies have significantly enhanced the 
knowledge about the biological functions of Set2/H3K36me, raised interesting new questions 
relevant to genomic integrity and their connections to human health.  
4.3 Disease Relevance 
 The Cancer Genome Atlas (TCGA) has made significant efforts to molecularly characterize 
cancer genomes, in order to understand the genetic basic for tumorigenesis and develop new 
therapeutic regimens. This massive effort has resulted in the realization that chromatin 
components are one of the most frequently mutated genes, with significant correlations to patient 
prognosis. Loss of function mutations, loss of heterozygosity and over-expression of several 
chromatin modifiers have come to define the epigenetic landscape of the cancer genome. Effects 
on mis-regulated transcriptional landscape drive some of the phenotypes seen after mis-
regulation of chromatin factors, but that is not the complete story. A large number of these 
chromatin modifiers are major regulators of genomic integrity and inappropriate chromatin 
modification/ regulation will impinge on the mutational potential, landscape and the downstream 
adaptability of cancer cells. One such chromatin modifier is the human homolog of Set2, 
SETD2, which is responsible for H3K36me3 in human cells. 
  
 98 
 SETD2 is significantly mutated in clear cell renal carcinoma (ccRCC), a type of kidney cancer, 
glioblastoma multiformae (GBMs) and bladder cancer. Curiously, another important driver 
mutation in GBM is the mutation of lysine 9 and 36 of histone H3 variant, H3F3A, to 
Methionine, which results in loss of H3K9me3 and H3K36me3 in these cells. Some of the 
functions in SETD2 lacking ccRCC cells as well as H3K36M mutant cells arise from the effect 
of SETD2 on alternative splicing. However, work from Guo Min-Li and Tim Humphrey clearly 
shows that loss of H3K36me3 increases the mutational landscape of ccRCC cells- through mis-
regulated mismatch repair and double strand break repair. In terms of mismatch repair, 
H3K36me3 was shown to recruit MSH6, through a PWWP domain, and stabilize and facilitate 
its activity on S-phase chromatin. Thus, presence of SETD2 resulted in more proficient 
mismatch repair in S-phase in human cells. Work from the Humphrey lab shows that H3K36me3 
recruits PSIP1/p75/LEDGEF protein, which facilitates the recruitment of human CTIP protein. 
CTIP is required for resection after DSB and hence mis-regulated CTIP recruitment increases the 
cell’s ability to shunt the DSB from HR to MMEJ and thereby increases genomic abnormalities. 
Interestingly, even the over-expression of the demethylase that removes H3K36me3, JMJD2A, is 
tumorigenic. Seminal work from the Whetstine laboratory reveals that over-expression of 
JMJD2A results in H3K36me3, along with H3K9me3, and hence results in open chromatin 
structure. Such an open chromatin structure is conducive for recruitment of MCM complex to 
certain areas of the genome, resulting in re- replication of the genome. In addition, even 
H3K36me2 has emerged as a major regulator of genome integrity and transcription regulation in 
human cells. H3K36me2 catalyzed by the non-SET domain containing H3K36me2 transferase, 
SETMAR, helps in recruitment of human Ku70-80 and thus promote NHEJ-dependent repair of 
DSBs. In human cells, NSD2 also regulates H3K36me2 and over expression of NSD2 correlated 
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with more aggressive tumors in mouse models and over-all mis-regulated transcription of NF-kB 
regulated transcripts. In sum, over the past years, our work and others’ have established Set2 and 
H3K36 methylation as a major regulator of genome function- both in transcription and DNA 
repair and paved the way for appropriate targeting of this critical chromatin modifier in human 
disease, most critically in cancer. 
4.4. Conclusion for chapter 3: 
 A canonical nucleosome consists of two copies each of histones- H2A, H2B, H3 and H4 4. 
They form what are called core histones and are synthesized in a replication-dependent manner 
45. On the contrary, different versions of these core histones exist in all eukaryotes, which gets 
incorporated in a time and genomic location dependent manner. Histone H44444222A has the most 
number of variants, among all and Htz1 (mammalian H2A.Z) is one of the most conserved 
variant from yeast to human 41. It is ~60% identical to the canonical histone H2A but the 
difference between H2A and Htz1 results in very profound changes in the biophysical characters 
of the Htz1-containing nucleosomes 41. For these regions, histone variants, in general, and Htz1, 
in particular, acts as a bookmark for the genome. Htz1 is present at the -1 and +1 nucleosomes 
and sub-telomeric heterochromatin. Htz1 is typically depleted in the gene bodies 46-48. The idea 
behind the presence of Htz1 at -1 and +1 nucleosome is to allow for a more easily dissociable 
nucleosome, such that transcription activation can be facilitated. In addition, Htz1 deposition is 
also regulated around a double-strand break and centromeres 94,114.  
 The machinery for the deposition of Htz1 in budding yeast involves a myriad number of 
histone acetyltransferases, histone chaperones and ATP-dependent chromatin remodeling 94. 
Deposition of Htz1 in the chromatin is driven by a sequential set of events involving the import 
of Htz1-H2B dimer into the nucleus with the help of Nap1 histone chaperone 94. Subsequently, 
  
 100 
Nap1 is supposed to deliver Htz1-H2B to SWR1 chromatin remodeling complex 94. SWR1 is a 
multi-protein complex containing the actual ability to deposit histones into the chromatin, using 
the energy of ATP.  SWR1 relies on a hierarchical binding to the linker DNA around the NFR 
region at the promoter and the hyperacetylated H3/H4 around the promoter 95,96. SWR1 complex 
has subunits that can physically bind to the DNS (RuvB family members). In addition, SWR1 
has a facultative subunit, Bdf1, which contains bromo-domains, which bind to acetylated 
histones 48,95. Bdf1 has been shown to be interacting with acetylated histone H3/H4, one primary 
reason why Htz1 is restricted to the promoter region 48,95. In addition to the Nap1-dependent 
delivery of Htz1-H2B dimer to SWR1, Chz1 is another chaperone, which is specific for Htz1-
H2B dimer and delivers this dimer to SWR1 for eventual deposition 99. However, the fraction of 
Htz1 deposition being dependent upon Nap1 or Chz1 is currently unknown. Additionally, 
contrary to the notion that Nap1 and Chz1 are redundantly functioning, nap1Δ and chz1Δ do not 
phenocopy each other on caffeine or benomyl 94.  
 Although a lot of stress is typically put on the deposition of histone variants, equally 
important is their eviction from the chromatin. This is evidenced by the observation that 
inappropriate deposition of the centromeric histone H3 variant, Cse4, in the chromatin results in 
genomic instability and there are elaborate SWI/SNF and FACT dependent mechanisms to evict 
the inappropriately deposited the Cse4 94. In chapter 3 of this study, we show that Htz1 is 
aberrantly deposited around the DSB, and which eventually results in a permissive chromatin 
structure and inappropriate DSB processing. In chapter 3, we provided biochemical evidence for 
a novel function of Nap1 and Chz1 in removing the Htz1. We showed that loss of Nap1 or Chz1 
or both, increases the levels of Htz1 in the chromatin. Using molecular modeling and docking 
(onto a Chz1- Htz1 nucleosome), we predicted critical residues for interactions with both Chz1 
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and Nap1. We showed that the interaction surfaces for Chz1 and Nap1 are only partially 
overlapping, and therefore the two chaperones are only partially redundant in terms of their 
Htz1-related functions. We showed the biological significance of these residues (caffeine and 6- 
azauracil sensitivity). Finally, our unbiased analysis revealed a mutation in Htz1 (Y65K), which 
when expressed in cells, result in extremely low levels of htz1 and has slow growth phenotypes 
both with drugs and without drugs. Interestingly, we can show that Y65K is present in 
chromatin, albeit at extremely low levels and deletion of the Htz1 deposition almost completely 
restores the Htz1 levels and viability to different stressors.  
 In addition, INO80 complex has been also shown to function in the eviction of Htz1 
containing nucleosomes and replacing it with H2A-nucleosomes 37,171. After the activation of 
DNA damage checkpoint, INO80 complex removes Htz1 containing nucleosomes from around 
the DSB in favor or H2A nucleosomes 37. This, in turn, increases the amount of likely substrates 
for Mec1/Tel1 i.e. phosphorylation of H2A Serine 129phosphorylation (Y-H2A.X). Later on the 
Peterson group also showed that INO80 is not only required for removal of Htz1 from chromatin 
around a DSB, but it is also required for removing Htz1 from non-specific places in the genome 
171. Furthermore, it was recently shown that loss of Arp5 subunit of INO80 complex, increases 
the amount of Htz1 present in +1 nucleosomes, genome-wide, providing another evidence that 
removal of histone variants from chromatin is as per much important, if not more, as their 
deposition 95.  
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4.5 Unanswered Questions and Perspective: 
 Studies in chapter 3 have opened up a lot of interesting questions regarding Htz1 biology and 
the functions of these Htz1 chaperones in cellular functions. Some of these questions, with 
potential experimental strategies will be discussed subsequently: 
1. What areas of the genome show increased deposition of Htz1 in nap1del and chz1 del? 
Given that we show that, by immunoblot, that Htz1 levels in the chromatin in the nap1del 
and chz1 del is significantly more than the wild type cells. However, we do not provide 
any further evidence regarding the genomic locations that are most affected. One 
possibility is that, INO80 is primarily responsible for removing Htz1 from +1 
nucleosomes near the promoter, while Nap1 and Chz1 (in conjunction with a chaperone, 
INO80 or something else) helps in removing Htz1 from within gene bodies. Another 
attractive possibility can come from the possibility that in nap1Δ and chz1Δ, the Htz1 
enrichment is coming from centromere, telomere and other heterochromatic environment. 
The second possibility is supported by the observation that nap1Δ and chz1Δ have 
sensitivities to microtubule depolymerizing agent, Benomy, arresting yeast cells in G2/M. 
To get at either possibility, we can isolate the MNase-digested chromatin (producing only 
mono-nucleosome fractions) and then perform a ChIP followed by high-throughput 
sequencing experiment (ChIP-seq) for Htz1. We have already standardized the 
procedures for MNase-ChIP for Htz1 in wild type, htz1Δ, nap1Δ, chz1Δ and nap1Δchz1Δ 
and we hope to address this question in the near future.  
2. Neither Nap1 nor Chz1 have an enzymatic activity that can allow them to dismantle an 
Htz1-containing nucleosome and exchange it out of the chromatin. This raises the 
possibility that Nap1 and Chz1 are working in conjunction with another chaperone. One 
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way to address this possibility is to observe functional interactions (genetic and physical) 
between NAP1, CHZ1 and canonical chaperones Htz1 such as SWR1, INO80 and FUN30. 
If Nap1 and Chz1 functions through any of these canonical chaperones, we would be able 
to identify a complex with Nap1-Htz1- and one of these (or other candidate chaperones) 
by using co-immunoprecipitation experiments.  
3. We have shown that Y65K is expressed, at the protein level, at extremely low levels, but 
it is still deposited in the chromatin. We have not yet shown the ability of this mutant 
version of Htz1 to bind to SWR1 or other Htz1-depositing chaperones. This can be tested 
by co-immunoprecipitation experiments between Y65K and components of SWR1 
complex. We can follow this up with a ChIP-seq experiment for Htz1 (Y65K) to identify 
the regions where Y65K can get deposited in the chromatin. This will reveal the 
fundamental reason why the Y65K mutant is slow growing and is sick in response to 
multiple stressors, typically to a greater extent than an htz1del.  
Histone variants have emerged as a critical regulator of transcription, 
heterochromatin structure, genome maintenance and cell cycle regulation. In line with 
these findings, mutations in the H3.3 variant of histone H3, H3.3K9M and H3.3K36M, 
are driver mutations for pediatric glioblastoma multiformae (GBMs) 42,52-54. Additionally, 
H2A.Z deletion is embryonically lethal in mammals thereby revealing the major role 
H2A.Z plays in organismal development 94 and emphasizing the multi-faceted function of 
H2A.Z in cellular processes.  
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Table 5. LIST OF YEAST STRAINS USED IN CHAPTER 2 
Strains Relevant Genotype Source 
BY4741 MATa his3∆0 leu2∆0 met15∆0 ura3∆0 
 
Open Biosystems 
set2Δ 
 
MATa his3∆0 leu2∆0 met15∆0 ura3∆0 
set2Δ::NATMX 
 
This study 
yku70Δset2Δ 
 
MATa his3∆0 leu2∆0 met15∆0 ura3∆0 
yku70Δ::HPHset2Δ::NATMX 
 
This study 
asf1Δset2Δ 
 
MATa his3∆0 leu2∆0 met15∆0 ura3∆0 
asf1Δ::KANMXset2Δ::NATMX 
 
This study 
rad51Δset2Δ 
 
MATa his3∆0 leu2∆0 met15∆0 ura3∆0 
rad51Δ::KANMXset2Δ::NATMX 
 
this study 
 
JKM179 HOΔ, hmlΔ::ADE1, MATalpha, hmrΔ::ADE1, ade1-
100, leu2,3-112, lys5, trp::hisG, ura3-52, 
ade3::GAL::HO 
James Haber, 
Brandeis University 
 
JKM179set2Δ 
 
HOΔ, hmlΔ::ADE1, MATalpha, hmrΔ::ADE1, ade1-
100, leu2,3-112, lys5, trp::hisG, ura3-52, 
ade3::GAL::HO set2Δ::KANMX  
 
 
This study 
JKM179yku70Δ 
 
HOΔ, hmlΔ::ADE1, MATalpha, hmrΔ::ADE1, ade1-
100, leu2,3-112, lys5, trp::hisG, ura3-52, 
ade3::GAL::HO yku70Δ::KANMX 
 
This study 
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JKM179yKu80- 
9Myc 
 
HOΔ, hmlΔ::ADE1, MATalpha, hmrΔ::ADE1, ade1-
100, leu2,3-112, lys5, trp::hisG, ura3-52, 
ade3::GAL::HO YKU80::YKU80-9MYC::KAN 
 
This study 
JKM179yKu80- 
9Myc 
 
HOΔ, hmlΔ::ADE1, MATalpha, hmrΔ::ADE1, ade1-
100, leu2,3-112, lys5, trp::hisG, ura3-52, 
ade3::GAL::HO YKU80::YKU80-
9MYC::KANset2Δ::HPH 
 
This study 
WT (H3-H4 
shuffle; WZY42)  
 
MATa, ura3–52, lys2–801, ade2–101, trp1∆63, 
his3∆200, leu2∆1, hht1- hhf1::pWZ405-F2F9-
LEU2,hht2- hhf2::pWZ403-F4F10-HIS3, Ycp50-
copyII (HHT2-HHF2, URA3+) 
 
Zhang et.al; EMBO 
Journal; 17-11; 3155- 
3167, 1998 
 
H3K36A 
 
same as above, except Ycp50-copyII (HHT2K36A-
HHF2, TRP+) 
 
Zhang et.al; EMBO 
Journal; 17-11; 3155- 
3167, 1998 
 
WT (H3-H4 
shuffle)  
 
MATa his3Δ200 leu2Δ1 ura3-52 trp1Δ63 lys2-128δ 
(hht1-hhf1)Δ::LEU2 (hht2- hhf2)Δ::HIS3 
Ty912Δ35-lacZ::his4 <pDM9> 
 
Duina And Winston; 
MCB; 24; 2; 561-572 
 
K36A 
 
MATa his3Δ200 leu2Δ1 ura3-52 trp1Δ63 lys2-128δ 
(hht1-hhf1)Δ::LEU2 (hht2- hhf2)Δ::HIS3 
Ty912Δ35-lacZ::his4 <pK36A> 
 
Jerry L. Workman, 
Stowers Institute, 
 
K56R 
 
MATa his3Δ200 leu2Δ1 ura3-52 trp1Δ63 lys2-128δ 
(hht1-hhf1)Δ::LEU2 (hht2- hhf2)Δ::HIS3 
Ty912Δ35-lacZ::his4 <pK56R> 
 
Jerry L. Workman, 
Stowers Institute, 
 
 
K36AK56R 
MATa his3Δ200 leu2Δ1 ura3-52 trp1Δ63 lys2-128δ 
(hht1-hhf1)Δ::LEU2 (hht2- hhf2)Δ::HIS3 
Jerry L. Workman, 
Stowers Institute, 
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 Ty912Δ35-lacZ::his4 <pK36AK56R> 
 
 
DY150 
 
MATa ade2 can1 his3 leu2 trp1 ura3 
(W303) 
 
David Stillman, 
University of Utah 
 
htz1Δ 
 
as above except htz1Δ::KanMX 
 
David Stillman, 
University of Utah 
 
set2Δ 
 
DY150 set2Δ::Hph 
 
This study 
htz1Δset2Δ 
 
DY150 set2Δ::Hph htz1Δ::KanMX 
 
this study 
 
YMS196 set2Δ YMS196 except set2Δ::NATMX 
 
YMS196 obtained 
from Nevan Krogan, 
UCSF 
 
SP1173 WT 
(S.pombe) 
 
h- leu1-32 his2 ura4 ade6-216 
 
Shiv Grewal, NCI 
 
SP1173 set2Δ 
(S.pombe)  
 
same as above except set2Δ::KanMX 
 
Raghuvar 
Dronamraju and 
Brian Strahl, 
unpublished 
 
KSC1785 
 
MATa-inc ADH4cs::HIS2 ade1 his2 leu2 trp1 ura3 
(bar1Δ::NATMX) 
 
Nakada et.al Genes 
and Development, 
2003; 17(16) 1957- 
1962) 
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KSC1785set2Δ 
 
same as above except set2Δ::HpHMX and 
bar1Δ::NA TMX 
 
this study 
 
W303 
 
MATa ade2 can1 his3 leu2 trp1 ura3 
 
Strahl lab 
 
spt16-11 MATa spt16-11 ade2 can1 his3 leu2 lys2 met15 trp1 
ura3 
 
David Stillman, 
University of Utah 
(DY8107) 
 
set2Δ 
 
MATa ade2 can1 his3 leu2 trp1 ura3 
set2Δ::HpHMX 
 
Stephen McDaniel 
and Brian Strahl, 
unpublished 
 
spt16-11set2Δ 
(YSM167) 
 
 
MATa spt16-11 set2::HpHMX ade2 can1 his3 leu2 
ura3 
 
Stephen McDaniel 
and Brian Strahl, 
unpublished 
 
W3031A 
 
MATa leu2-3,112 his3-11,15 ade2-1 ura3-1 trp1-1 
can1-100 
 
Taschner et.al; 
Molecular and 
Cellular Biology; 
2010; 436– 446 
 
JSY1112 
 
 
MATa leu2-3,112 his3-11,15 ade2-1 ura3-1 trp1-1 
can1-100 mec1::HIS3 sml1::TRP1 
 
Taschner et.al; 
Molecular and 
Cellular Biology; 
2010; 436– 446 
 
JSY1113 MATa leu2-3,112 his3-11,15 ade2-1 ura3-1 trp1-1 
can1-100 chk1 ::HIS3 
Taschner et.al; 
Molecular and 
Cellular Biology; 
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  2010; 436– 446 
 
JSY1114 
 
MATa leu2-3,112 his3-11,15 ade2-1 ura3-1 trp1-1 
can1-100 rad53::HIS3 sml1::TRP1 
 
Taschner et.al; 
Molecular and 
Cellular Biology; 
2010; 436– 446 
 
JKM139set2Δ 
 
MATa hmrΔ::ADE1 hmlΔ::ADE1 ade1-100 leu2-
3,112 lys5 trp1::hisG ura3-52 ade3::GAL-
HOset2Δ::KANbar1Δ::NAT 
 
This study 
JKM139 
 
 MATa hmrΔ::ADE1 hmlΔ::ADE1 ade1-100 leu2-
3,112 lys5 trp1::hisG ura3-52 ade3::GAL-
Hobar1Δ::NATMX 
 
James Haber, 
Brandeis University, 
bar1Δ::NAT was 
performed in this 
study. 
 
rad59Δset2Δ 
 
MATa his3∆0 leu2∆0 met15∆0 ura3∆0 
rad59Δ::KANMXset2Δ::NA TMX 
 
This study 
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Table 6. LIST OF YEAST STRAINS USED IN CHAPTER 3 
Strains          Relevant Genotype Source 
BY4741 MAT a (his3-D1 leu2-D0 met15-D0 ura3-D0) 
Open 
Biosystems 
YMP210 
MAT a (his3-D1 leu2-D0 met15-D0 ura3-D0), plus pRS316 (CEN6 
URA) 
This study 
YMP050 MATa (his3-D1 leu2-D0 met15-D0 ura3-D0; htz1D::KanMX4) 
Open 
Biosystems 
YMP295 MATa (his3-D1 leu2-D0 met15-D0 ura3-D0; nap1D::KanMX4) 
Open 
Biosystems 
YMP211 MATa (his3-D1 leu2-D0 met15-D0 ura3-D0; chz1D::KanMX4) 
Open 
Biosystems 
YMP351 MATa (his3-D1 leu2-D0 met15-D0 ura3-D0; swc2D::KanMX4) 
Open 
Biosystems 
YMP179 MATa (his3-D1 leu2-D0 met15-D0 ura3-D0; swr1D::KanMX4) 
Open 
Biosystems 
YMP296 
MATa (his3-D1 leu2-D0 met15-D0 ura3-D0; nap1D::KanMX4), 
plus pRS316 (CEN6 URA) 
This study 
YMP293 
MATa (his3-D1 leu2-D0 met15-D0 ura3-D0; swr1D::KanMX4), 
plus pRS316 (CEN6 URA) 
This study 
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YMP352 
MATa (his3-D1 leu2-D0 met15-D0 ura3-D0; swc2D::KanMX4), 
plus pRS316 (CEN6 URA) 
This study 
YMP213 
MATa his3-D1 leu2-D0 met15-D0 ura3-D0 CHZ1-TAP 
htz1D::kanMX4 
This study 
YMP216 
MATa his3-D1 leu2-D0 met15-D0 ura3-D0 NAP1-TAP 
htz1D::kanMX4 
This study 
YMP077 Isogenic to YMP050, plus pRS316 (CEN6 URA) This study 
YMP065 Isogenic to YMP050, plus pMP008 (CEN6 URA H2A.Z) This study 
YMP286 Isogenic to YMP050, plus pMP115 (CEN6 URA h2a.z L93T) This study 
YMP287 Isogenic to YMP050, plus pMP116 (CEN6 URA h2a.z Y65K) This study 
YMP288 Isogenic to YMP050, plus pMP117 (CEN6 URA h2a.z R48D)  This study 
YMP289 Isogenic to YMP050, plus pMP119 (CEN6 URA h2a.z R39D) This study 
YMP290 Isogenic to YMP050, plus pMP120 (CEN6 URA h2a.z D98K) This study 
YMP291 Isogenic to YMP050, plus pMP121 (CEN6 URA h2a.z S53L) This study 
YMP292 Isogenic to YMP050, plus pMP122 (CEN6 URA h2a.zN76M) This study 
YMP298 
MATa (his3-D1 leu2-D0 met15-D0 ura3-D0; swr1D::KanMX4 
htz1D::NatMX) 
This study 
YMP300 MATa (his3-D1 leu2-D0 met15-D0 ura3-D0; nap1D::KanMX4 This study 
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htz1D::NatMX) 
YMP301 
MATa (his3-D1 leu2-D0 met15-D0 ura3-D0; swc2D::KanMX4 
htz1D::NatMX) 
This study 
YMP307 Isogenic to YMP213, plus pMP008 (CEN6 URA H2A.Z) This study 
YMP308 Isogenic to YMP213, plus pMP115 (CEN6 URA h2a.z L93T) This study 
YMP310 Isogenic to YMP213, plus pMP117 (CEN6 URA h2a.z R48D) This study 
YMP311 Isogenic to YMP213, plus pMP119 (CEN6 URA h2a.z R39D) This study 
YMP313 Isogenic to YMP213, plus pMP121 (CEN6 URA h2a.z S53L) This study 
YMP314 Isogenic to YMP213, plus pMP122 (CEN6 URA h2a.z N76M) This study 
YMP316 Isogenic to YMP216, plus pMP008 (CEN6 URA H2A.Z) This study 
YMP317 Isogenic to YMP216, plus pMP115 (CEN6 URA h2a.z L93T) This study 
YMP319 Isogenic to YMP216, plus pMP117 (CEN6 URA h2a.z R48D) This study 
YMP320 Isogenic to YMP216, plus pMP119 (CEN6 URA h2a.z R39D) This study 
YMP322 Isogenic to YMP216, plus pMP121 (CEN6 URA h2a.z S53L) This study 
YMP323 Isogenic to YMP216, plus pMP122 (CEN6 URA h2a.z N76M) This study 
YMP324 Isogenic to YMP298, plus pRS316 (CEN6 URA) This study 
YMP325 Isogenic to YMP298, plus pMP008 (CEN6 URA H2A.Z) This study 
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YMP326 
Isogenic to YMP298, plus plasmid pMP115 (CEN6 URA h2a.z 
L93T) 
This study 
YMP327 
Isogenic to YMP298, plus plasmid pMP116 (CEN6 URA h2a.z 
Y65K) 
This study 
YMP328 
Isogenic to YMP298, plus plasmid pMP117 (CEN6 URA h2a.z 
R48D) 
This study 
YMP329 
Isogenic to YMP298, plus plasmid pMP119 (CEN6 URA h2a.z 
R39D) 
This study 
YMP330 
Isogenic to YMP298, plus plasmid pMP120 (CEN6 URA h2a.z 
D98K) 
This study 
YMP331 
Isogenic to YMP298, plus plasmid pMP121 (CEN6 URA h2a.z 
S53L) 
This study 
YMP332 
Isogenic to YMP298, plus plasmid pMP122 (CEN6 URA h2a.z 
N76M) 
This study 
YMP333 Isogenic to YMP300, plus plasmid pRS316 (CEN6 URA) This study 
YMP334 Isogenic to YMP300, plus plasmid pMP008 (CEN6 URA H2A.Z) This study 
YMP335 
Isogenic to YMP300, plus plasmid pMP115 (CEN6 URA h2a.z 
L93T) 
This study 
YMP336 Isogenic to YMP300, plus plasmid pMP116 (CEN6 URA h2a.z This study 
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Y65K) 
YMP337 
Isogenic to YMP300, plus plasmid pMP117 (CEN6 URA h2a.z 
R48D) 
This study 
YMP338 
Isogenic to YMP300, plus plasmid pMP119 (CEN6 URA h2a.z 
R39D) 
This study 
YMP339 
Isogenic to YMP300, plus plasmid pMP120 (CEN6 URA h2a.z 
D98K) 
This study 
YMP340 
Isogenic to YMP300, plus plasmid pMP121 (CEN6 URA h2a.z 
S53L) 
This study 
YMP341 
Isogenic to YMP300, plus plasmid pMP122 (CEN6 URA h2a.z 
N76M) 
This study 
YMP342 Isogenic to YMP301, plus plasmid pRS316 (CEN6 URA) This study 
YMP343 Isogenic to YMP301, plus plasmid pMP008 (CEN6 URA H2A.Z) This study 
YMP344 
Isogenic to YMP301, plus plasmid pMP115 (CEN6 URA h2a.z 
L93T) 
This study 
YMP345 
Isogenic to YMP301, plus plasmid pMP116 (CEN6 URA h2a.z 
Y65K) 
This study 
YMP346 
Isogenic to YMP301, plus plasmid pMP117 (CEN6 URA h2a.z 
R48D) 
This study 
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YMP347 
Isogenic to YMP301, plus plasmid pMP119 (CEN6 URA h2a.z 
R39D) 
This study 
YMP348 
Isogenic to YMP301, plus plasmid pMP120 (CEN6 URA h2a.z 
D98K) 
This study 
YMP349 
Isogenic to YMP301, plus plasmid pMP121 (CEN6 URA h2a.z 
S53L) 
This study 
YMP350 
Isogenic to YMP301, plus plasmid pMP122 (CEN6 URA h2a.z 
N76M) 
This study 
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